US20220154241A1 - Enzymatic circuits for molecular sensors - Google Patents
Enzymatic circuits for molecular sensors Download PDFInfo
- Publication number
- US20220154241A1 US20220154241A1 US17/586,772 US202217586772A US2022154241A1 US 20220154241 A1 US20220154241 A1 US 20220154241A1 US 202217586772 A US202217586772 A US 202217586772A US 2022154241 A1 US2022154241 A1 US 2022154241A1
- Authority
- US
- United States
- Prior art keywords
- enzyme
- circuit
- polymerase
- electrodes
- molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002255 enzymatic effect Effects 0.000 title description 4
- 102000004190 Enzymes Human genes 0.000 claims abstract description 213
- 108090000790 Enzymes Proteins 0.000 claims abstract description 213
- 230000037361 pathway Effects 0.000 claims abstract description 13
- 239000000758 substrate Substances 0.000 abstract description 27
- 230000006870 function Effects 0.000 abstract description 4
- 238000000034 method Methods 0.000 description 32
- 235000001014 amino acid Nutrition 0.000 description 26
- 108020004414 DNA Proteins 0.000 description 25
- 230000021615 conjugation Effects 0.000 description 23
- 108090000765 processed proteins & peptides Proteins 0.000 description 20
- 235000018417 cysteine Nutrition 0.000 description 19
- 102100034343 Integrase Human genes 0.000 description 18
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 18
- 239000000872 buffer Substances 0.000 description 18
- 150000001413 amino acids Chemical group 0.000 description 17
- 230000008859 change Effects 0.000 description 15
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 15
- 102000053602 DNA Human genes 0.000 description 12
- 230000008901 benefit Effects 0.000 description 12
- 239000002800 charge carrier Substances 0.000 description 12
- 230000011664 signaling Effects 0.000 description 12
- 125000003275 alpha amino acid group Chemical group 0.000 description 11
- 230000033001 locomotion Effects 0.000 description 11
- 230000008569 process Effects 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 10
- 230000008878 coupling Effects 0.000 description 10
- 238000010168 coupling process Methods 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 238000005442 molecular electronic Methods 0.000 description 9
- 239000010931 gold Substances 0.000 description 8
- 229910052737 gold Inorganic materials 0.000 description 8
- 230000003993 interaction Effects 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 150000001768 cations Chemical class 0.000 description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 7
- 230000000977 initiatory effect Effects 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- 108010017826 DNA Polymerase I Proteins 0.000 description 6
- 102000004594 DNA Polymerase I Human genes 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 108020004682 Single-Stranded DNA Proteins 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 150000001945 cysteines Chemical class 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000002074 nanoribbon Substances 0.000 description 4
- 238000004611 spectroscopical analysis Methods 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 108091093037 Peptide nucleic acid Proteins 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 210000003811 finger Anatomy 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000005439 maleimidyl group Chemical group C1(C=CC(N1*)=O)=O 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000004001 molecular interaction Effects 0.000 description 3
- 239000002070 nanowire Substances 0.000 description 3
- 229920005615 natural polymer Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 238000010408 sweeping Methods 0.000 description 3
- 229920001059 synthetic polymer Polymers 0.000 description 3
- 210000003813 thumb Anatomy 0.000 description 3
- 230000006820 DNA synthesis Effects 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 125000003636 chemical group Chemical group 0.000 description 2
- -1 cysteine amino acids Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000009088 enzymatic function Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 229910021389 graphene Inorganic materials 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920000620 organic polymer Polymers 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 125000003396 thiol group Chemical group [H]S* 0.000 description 2
- 150000003573 thiols Chemical group 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- HIQYTCYQOKMFPP-WNQIDUERSA-N (2r)-2-amino-3-sulfanylpropanoic acid;pyrrole-2,5-dione Chemical compound SC[C@H](N)C(O)=O.O=C1NC(=O)C=C1 HIQYTCYQOKMFPP-WNQIDUERSA-N 0.000 description 1
- JARGNLJYKBUKSJ-KGZKBUQUSA-N (2r)-2-amino-5-[[(2r)-1-(carboxymethylamino)-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;hydrobromide Chemical compound Br.OC(=O)[C@H](N)CCC(=O)N[C@H](CO)C(=O)NCC(O)=O JARGNLJYKBUKSJ-KGZKBUQUSA-N 0.000 description 1
- 241000714266 Bovine leukemia virus Species 0.000 description 1
- XZWYTXMRWQJBGX-VXBMVYAYSA-N FLAG peptide Chemical group NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=C(O)C=C1 XZWYTXMRWQJBGX-VXBMVYAYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 241000713333 Mouse mammary tumor virus Species 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 229920000265 Polyparaphenylene Polymers 0.000 description 1
- 241000881705 Porcine endogenous retrovirus Species 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 241000714474 Rous sarcoma virus Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- 101150044878 US18 gene Proteins 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000009073 conformational modification Effects 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000002050 diffraction method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 108010044804 gamma-glutamyl-seryl-glycine Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002073 nanorod Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 108020001580 protein domains Proteins 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- 125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/002—Electrode membranes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
- G01N33/48721—Investigating individual macromolecules, e.g. by translocation through nanopores
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/001—Enzyme electrodes
- C12Q1/005—Enzyme electrodes involving specific analytes or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
- C12Q1/6825—Nucleic acid detection involving sensors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/10—Nucleotidyl transfering
- C12Q2521/101—DNA polymerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/60—Detection means characterised by use of a special device
- C12Q2565/607—Detection means characterised by use of a special device being a sensor, e.g. electrode
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/91245—Nucleotidyltransferases (2.7.7)
- G01N2333/9125—Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
- G01N2333/9126—DNA-directed DNA polymerase (2.7.7.7)
Definitions
- the present disclosure is generally directed to molecular sensors and more particularly to molecular sensors in which an enzyme closes the circuit between two electrodes.
- single molecule enzyme-based circuits wherein a single enzyme molecule is directly connected to a positive and negative electrode to form the circuit. These circuits are capable of yielding highly informative signals of enzyme activity. These improved signals have greater signal-to-noise levels such that the signals are more distinguishable from noise, and these improved signals include features that carry detailed information about the engagement between enzyme and the target substrate.
- a molecular sensor comprises an enzyme-based molecular circuit (conductive pathway) such as described herein.
- a sensor having a polymerase enzyme is usable to sense sequence information from a DNA template processed by the polymerase.
- a molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes.
- the enzyme of the circuit may comprise a first wiring point connected to the positive electrode and a second wiring point connected to the negative electrode.
- the circuit may further comprise at least one arm molecule having first and second ends, the first end bonded to the enzyme and the second end bonded to at least one of the electrodes, wherein the at least one arm molecule acts as an electrical wire between the enzyme and at least one of the electrodes.
- the at least one arm molecule may be selected from the group consisting of a double stranded oligonucleotide, a peptide nucleic acid duplex, a peptide nucleic acid-DNA hybrid duplex, a protein alpha-helix, a graphene-like nanoribbon, a natural polymer, a synthetic polymer, and an antibody Fab domain.
- At least one of the electrodes is connected to an internal structural element of the enzyme.
- the internal structural element may be selected from the group consisting of an alpha-helix, a beta-sheet, and a multiple of such elements in series.
- At least one of the electrodes may be connected to the enzyme at a location of the enzyme capable of undergoing a conformational change.
- At least one arm molecule may comprise a molecule having tension, twist or torsion dependent conductivity.
- the enzyme may comprise a polymerase.
- the polymerase comprises E. coli Pol I Klenow Fragment.
- the polymerase comprises a reverse transcriptase.
- the polymerase comprises a genetically modified reverse transcriptase.
- a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme comprising E. coli Pol I Klenow Fragment connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the polymerase at connection points within the major alpha-helix of the polymerase extending between amino acids at position 514 and 547.
- a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the sensor is usable to sense sequence information from a DNA template processed by the polymerase.
- a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the polymerase at connection points on the thumb and finger domains of the polymerase, and wherein such points undergo relative motion in excess of 1 nanometer as the polymerase processes a DNA template.
- the polymerase in this sensor is engineered to have extended domains which produce a greater range of relative motion as the polymerase processes a DNA template.
- the polymerase in this sensor is engineered to have additional charge groups that variably influence the internal conduction path as the enzyme processes a DNA template.
- the polymerase in this circuit is a genetically modified form of E. coli. Pol I, Bst, Taq, Phi29, or T7 DNA polymerases, or a genetically modified reverse transcriptase.
- a molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the enzyme at connection points in the enzyme comprising at least one of a native cysteine, a genetically engineered cysteine, a genetically engineered amino acid with a conjugation residue, or a genetically engineered peptide domain comprising a peptide that has a conjugation partner.
- this circuit further comprises a gate electrode.
- a method of sequencing a DNA molecule comprises: providing a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes; initiating at least one of a voltage or a current through the circuit; exposing the circuit to a solution containing primed single stranded DNA and/or dNTPs; and measuring electrical signals through the circuit as the polymerase engages and extends a template, wherein the electrical signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
- a method of molecular detection comprises, providing a circuit further comprising: a positive electrode; a negative electrode spaced apart from the positive electrode; a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes and a gate electrode; initiating at least one of a voltage or a current through the circuit; exposing the circuit to at least one of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode; and measuring an electrical change in the circuit.
- FIG. 1 illustrates the general concept of a molecular electronic circuit
- FIG. 2 illustrates the general concept of engaging an enzyme to a molecular electronic circuit, such as to act as a sensor of enzyme activity with its target;
- FIG. 3 illustrates an enzyme that is wired directly into the current path, in accordance with various embodiments
- FIG. 4 illustrates an enzyme that is wired directly into the current path, with the connection made to an internal alpha-helix structure within the enzyme, in accordance with various embodiments
- FIG. 5 illustrates an enzyme that is wired directly into the current path, with the connection made to a series of two or more internal alpha-helix structures in series within the enzyme, in accordance with various embodiments;
- FIG. 6 illustrates an enzyme that is wired directly into the current path, with the connection made to an internal beta-sheet structure within the enzyme, in accordance with various embodiments
- FIG. 7 illustrates an enzyme that is wired directly into the current path, such that connections are made to points of conformational change in the enzyme, to induce tension changes into the circuit during enzyme activity;
- FIG. 8 illustrates an enzyme that is wired directly into the current path, with additional connections made to stabilize the position of the enzyme
- FIG. 9 illustrates a schematic of an enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein the enzyme directly couples to the electrodes without the use of arm molecules;
- FIG. 10 illustrates a schematic of an enzyme directly wired by two points of contact into a circuit, as well as also having a one-point conjugation to a molecular wire, utilizing one pair of electrodes to measure the combined conduction, in accordance with various embodiments;
- FIG. 11 illustrates a schematic of an enzyme directly wired by two points of contact into a circuit, as well as also having a one-point conjugation to a molecular wire, utilizing two pairs of electrodes to measure these two modes of conduction independently, in accordance with various embodiments;
- FIG. 12 illustrates a protein structure view of the E. coli Pol I Klenow Fragment Polymerase enzyme, illustrating the presence of alpha-helix, beta-sheet, and connecting loop structures;
- FIG. 13 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein a specific alpha-helix is used for the contacts, and molecular arms provide coupling to the electrodes;
- FIG. 14 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein a specific alpha-helix is used for the contacts, and the polymerase directly couples to the electrodes without the use of arm molecules;
- FIG. 15 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein arms are wired to the points that undergo relative motion when the finger and thumb domains change relative conformation;
- FIG. 16 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, and where additional connecting arms are wired to provide stabilization and fixed spatial orientation.
- a molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes.
- the enzyme comprises a first wiring point connected to the positive electrode and a second wiring point connected to the negative electrode.
- enzyme means a molecule that acts to transform another molecule, by engaging with a variety of substrate molecules. Such transformation could include chemical modification, or conformational modification.
- Common biological enzyme classes are polymerases, ligases, nucleases, kinases, transferases, as well as genetically modified forms of these molecules.
- Polymerases herein include reverse transcriptases and any genetically modified reverse transcriptase, capable of directly acting on an RNA template.
- Enzymes are most commonly proteins, but may be composed of multiple amino acid chains, and may also be complexed with other types of molecules, such as RNA in the case of the ribosome enzyme.
- the term “substrate” for an enzyme refers to any of the molecules that the enzyme specifically engages with in the course of performing a transformation.
- the substrate in the specific case of a DNA polymerase, the substrate consists of both a template DNA and dNTPs.
- the enzyme may also complex with various co-factors that moderate its function or kinetics.
- divalent cations such as Mg++ are often essential cofactors, but not considered as substrates.
- dNTP or “dNTPs” refers to any of the deoxynucleotide triphosphates involved in polymerase-based DNA synthesis, or that can be engaged for such DNA synthesis, including both native and modified forms of such molecules.
- buffer for an enzyme refers to a solution in which the enzyme is viable and functional, and typically containing the substrates and co-factors needed for enzyme activity.
- Such an enzyme buffer may typically comprise salts, detergents, and surfactants, singly or in various combinations, as well as specific cofactors, such as magnesium or other divalent cations for a polymerase enzyme, along with the substrates, such as DNA and dNTPs for a polymerase enzyme.
- Such a buffer herein may have its composition modified from standard forms, such as to enhance signal properties in a sensor exposed to the buffer.
- Electrode means any structure that can act as an efficient source or sink of charge carriers. Most commonly these would be metal or semiconductor structures, such as those used in electronic circuits.
- a pair of spaced apart electrodes herein may comprise a source and drain electrode pair.
- a binding probe-based molecular circuit may further comprise a gate electrode.
- a gate electrode is used to apply a voltage rather than transfer charge carriers. Thus it supports accumulation of charge carriers to produce a local electric field, but is not intended to pass current.
- a gate electrode will be electrically isolated from the primary conduction paths of the circuit by some form of insulating layer or material.
- conjugation means any of the wide variety of means of physically attaching one molecule to another, or to a surface or particle. Such methods typically involve forming covalent or non-covalent chemical bonds, but may also rely on protein-protein interactions, protein-metal interactions, or chemical or physical adsorption via intermolecular (Van der Waals) forces. There is a large variety of such methods know to those skilled in the art of conjugation chemistry. Common conjugation methods relevant to preferred embodiments herein include thiol-metal bonds, maleimide-cysteine bonds, material binding peptides such as gold binding peptides, and click chemistries.
- an electrical current may be initiated in a circuit.
- Such initiating of a current may be the result of applying a voltage to the circuit, but may be from other actions to the circuit besides applying a voltage.
- a voltage may be initiated in a circuit.
- Such initiating of a voltage may be the result of applying a current to the circuit, but may be from other actions to the circuit besides applying an electrical current.
- a voltage or a current may be initiated in one portion of a circuit as the result of applying a voltage or a current to the overall circuit.
- a flow of electrons initiated from a negative to a positive electrode in a circuit of the present disclosure may be controlled by the voltage applied to the gate electrode of the circuit.
- a molecular sensor comprises an enzyme connected to both a positive and a negative electrode to complete a circuit. Interactions of the enzyme with various substrates are detectable as changes in the current or other electrical parameter measured across the circuit.
- the present molecular sensor differs from the general concept of a molecular electronic circuit in that the enzyme is directly “wired” to both the positive and negative electrodes rather than bonded to a molecular bridge molecule that spans the gap between the electrodes to complete a circuit.
- At least one of a voltage or a current is initiated in an enzyme-based molecular circuit.
- electrical changes in the circuit are sensed. These electrical changes, or informative electrical signals, may include current, voltage, impedance, conductivity, resistance, capacitance, or the like.
- a voltage is initiated in the circuit and then changes in the current through the circuit are measured as substrates interact with the enzyme.
- a current is initiated in the circuit, and changes to voltage in the circuit are measured as substrates interact with the enzyme.
- impedance, conductivity, or resistance is measured.
- the circuit further comprises a gate electrode, such as positioned underneath the gap between the positive and negative electrodes, at least one of a voltage or current may be applied to the gate electrode, and voltage, current, impedance, conductivity, resistance, or other electrical change in the circuit may be measured as substrates interact with the enzyme.
- FIG. 1 illustrates the general concept of a molecular electronic circuit having a bridge molecule 10 attached to and bridging the gap 12 between electrodes 15 , as well as some type of conjugation group 20 or other mechanism that binds the molecule to the electrodes (depicted as small shaded squares).
- FIG. 1 further illustrates that a current, (i), may pass through this molecule and be measured versus time, (t), as shown in the inset plot 25 .
- FIG. 2 illustrates a molecular electronic sensor in which an enzyme 30 is conjugated to the molecular bridge component 31 spanning the electrodes 32 , wherein monitoring the current provides a sensor for the enzyme engaging with and processing its target substrate 35 when exposed to a suitable buffer solution.
- the local charge perturbations that result from the target substrate engaging with the enzyme perturb charge transport through the primary bridge component, and are thus registered as a change in conductivity or current versus time, as indicated by the step-up change in the current (i) vs. time (t) current plot inset 38 in FIG. 2 .
- a molecular sensor comprises a single enzyme molecule directly wired into the circuit path, such that all electrical current passing through the molecular circuit must flow through the enzyme.
- the enzyme is an essential conduction path in the circuit, like an electronic component on a circuit board.
- FIG. 3 shows an enzyme 42 connected between molecular arms 40 .
- the enzyme may be coupled to both positive and negative electrodes at two or more points, such as to ensure that charge carriers traversing the molecular structure pass into and out of the enzyme.
- two molecular arms are conjugated to the enzyme to provide physical anchors and entry and exit paths for the current through the enzyme.
- Such arms may comprise any convenient molecule that provides a conducting connection or semi-conducting connection between the enzyme and the electrodes.
- molecular arms may provide spanning length extensions, to help span a larger electrode gap 55 that is wider than the 3D structure of the enzyme.
- Such arms may also provide the advantage of keeping the enzyme away from contacting the electrodes 65 where unfavorable or damaging interactions may occur with the electrodes, such as a denaturing adsorption to the electrode.
- Such arms may also provide for more compatible or efficient coupling to the electrodes, such as by coupling to the electrodes via chemical groups that are not readily found or made available on the enzyme.
- the electrode comprises gold and the molecular arm includes a thiol group, such that the arm couples to the gold electrode via well-known thiol-gold binding.
- the molecular arm accomplishes the binding while the enzyme may not have such available thiol groups.
- the arms may present a click-chemistry binding group, for coupling to electrodes that are derivatized with the cognate binding partners for the click chemistry.
- molecular arms comprise some form of conjugation 60 to the enzyme, as well as their conjugations or couplings to the electrodes.
- conjugation comprises chemical crosslinking, which can preferentially couple suitable chemical groups on the arms to amino acid residues on the enzyme.
- a maleimide group on the arm couples to a surface cysteine on the enzyme.
- genetically modified versions of an enzyme may be created and employed, such as enzymes comprising specific amino acids or protein domains engineered into their amino acid structure that provide specific conjugation sites. For example, cysteine amino acids engineered at specific sites on the enzyme provide for the attachment point of arms that present a maleimide group.
- one or more native cysteines that would provide competing arm binding sites may be “engineered out” of the amino acid sequence. If not all such sites can be removed, it is possible to use various purification methods from synthetic chemistry to isolate desired enzyme-arm conjugates from unwanted configurations.
- genetic methods are used to engineer into the amino acid sequence of the enzyme amino acids comprising residues that uniquely conjugate to a cognate group on the arms. This variation includes cases where non-standard amino acids are employed, such as amino acids modified to present a click-chemistry group, via protein expression systems that use a modified genetic code and modified transfer RNAs to put non-native amino acids at specific sequence sites in an expressed enzyme protein.
- a peptide domain that specifically binds with a cognate group on the arms is engineered into the sequence of a protein enzyme.
- a peptide that is an antigen to an antibody is engineered into the enzyme, and the Fab binding domain of the antibody is used on the arms.
- One such embodiment is to use the FLAG peptide motif DYKDD, and any suitable ANTI-FLAG Fab domain. Any other peptide antigens and their cognate Fab domains can similarly be used to conjugate arms to specific sites in an engineered enzyme protein, by engineering the peptide antigen into the desired conjugation sites on the enzyme.
- peptide domains make use of the SPY-TAG/SPY-CATCHER protein-protein binding system, by engineering either the SPY-TAG domain or the SPY-CATCHER domain into the enzyme protein, and placing the cognate domain in the arms.
- another embodiment is to add short linker peptide sequences flanking the target peptide, to enhance the availability of the domain for binding.
- short linkers may comprise short glycine and serine rich linkers, as are known to those skilled in the art of protein engineering, including, but not limited to, the linker amino acid sequences G, GS, GSG, GGSG, etc.
- the arm molecules comprise any molecules that provide for conduction of charge carriers into and out of the enzyme.
- such arms comprise molecular wires from the many forms known in field of molecular electronics, functionalized with suitable conjugation and binding groups for wiring to electrodes and enzyme.
- such arms may comprise single stranded DNA, double stranded DNA, peptides, peptide alpha-helices, antibodies, Fab domains of antibodies, carbon nanotubes, graphene nanoribbons, natural polymers, synthetic polymers, other organic molecules with p-orbitals for electron delocalization, or metal or semiconductor nanorods or nanoparticles.
- the arms may comprise double stranded DNA with thiol-bearing groups at one end, and maleimide at the other end that couples to the enzyme, or a peptide alpha-helix with a cysteine or gold binding peptide at one termini, and a maleimide at the other end that couples to the enzyme, or a graphene nanoribbon with thiol-bearing groups at one end, and a maleimide bearing group at the other end that couples to the enzyme.
- the two arm molecules used to couple an enzyme to two electrodes are identical molecules, and in other embodiments, the two arm molecules are different molecules.
- there may be a “positive electrode” arm and a “negative electrode” arm providing for oriented binding of an enzyme to the corresponding “positive” and “negative” electrodes in FIG. 3 .
- arm conjugation points connect directly to specific protein structural elements within the enzyme.
- FIG. 4 A non-limiting example is illustrated in FIG. 4 , where the arms 75 are shown wired directly to an alpha-helix structure 70 in the enzyme 72 .
- Such structural elements provide preferential conduction paths through the enzyme.
- Direct wiring to natural conduction paths in the enzyme guide current closer to active regions of interest within the enzyme, such as substrate binding pockets, and may thereby provide for further enhanced current signals, or current signals that carry more information on enzyme-substrate interactions.
- FIG. 4 one embodiment is shown in FIG. 4 , where the arms wire directly to an alpha-helix that spans between two points on or near the surface of the enzyme. Another example is shown in FIG.
- a protein enzyme will have a 3D structure that includes well known secondary structural elements such as alpha-helices and beta-sheets. These are primarily hydrogen bonded structures that can provide discrete conduction paths through the body of the enzyme, to the extent that current carriers, such as electrons, may efficiently hop along such structures, or along the hydrogen bonds that define such structures, with less resistance than otherwise hopping or tunneling off such structures. These structures provide preferential conduction paths that will channel charge carriers, and by selecting such structures, charge is forced to pass close to active regions of the enzyme, and current-based sensing of the activity will be improved.
- the wiring can be to such structures that appear in the enzyme “in series”, such as for example, two alpha-helices in series as indicated in FIG. 5 , or a beta-sheet in series with an alpha-helix, or three successive alpha-helices.
- each successive element in series appears in the enzyme primary amino acid sequence as separated from the previous element by a small number of amino acids, such 0, 1, 2, or up to approximately 10 amino acids, which typically form a connecting loop in the secondary structure.
- Wiring of elements in series may also be achieved by wiring to structures that are not contiguous in the primary amino acid sequence of the enzyme, but are nonetheless spatially contiguous and in conductive contact, and form a preferred conduction path, owing to hydrogen bonding, salt bridges, disulfide bridges, or other types of molecular interaction that establish secondary, tertiary or quaternary protein structure and that can provide a clearly defined and favorable conduction path from one structural element (beta-sheet, alpha-helix) to another.
- These structural elements of interest for wiring are most evident when examining the 3D structure of the proteins involved, as can be observed from the crystal structures, and in particular, by examination of the protein structures obtained by X-ray or NMR crystallography. This useful form of structural information is illustrated by the polymerase enzyme structure shown in FIG. 12 .
- the arms are wired to points on the enzyme that undergo conformation changes or relative motion during enzyme function, such as illustrated in FIG. 7 .
- the arms 105 are wired to two points 110 that are indicated as having relative motion, as illustrated in the inset 108 , during enzyme activity.
- This configuration can enhance signaling by several means. First, such motions can change the tension in the arms, and it is known that tension changes in molecules can change their conductivity, thus the motion may be transduced via tension into a change in conductivity of the arms, which consequently show up in the current signals. In this way, the current may contain information about the conformational changes in the enzyme. Second, similarly, this configuration can cause tension in the enzyme as it changes conformation, and thus alter conductivity of the enzyme.
- an enzyme is engineered to have extended regions that undergo greater conformational change or relative motion (e.g. as demonstrated by extending the length of the two tips of the scissor-shaped enzyme indicated in FIG. 7 ), so as to enhance the range of motion, and therefore the range of tension changes in the arms and enzymes.
- conformational changes in the enzyme are translated into a twist, torque or rotation of at least one arm, and that twist, torsion or rotation alters the conductivity of the arm.
- an arm comprising an organic polymer further comprising polycyclic aromatic rings, such as polythiophene or polyphenylene, whereby previously lined up p-orbitals are rotated out of alignment by C—C bond rotation when the arm is twisted, torqued or rotated in response to an enzyme conformational change.
- the electrons have impeded delocalization through the organic polymer.
- such impeded flow may act on only a subset of the charge carriers, depending on, for example, the polarization or other quantum state of the charge carrier, such as spin polarization of an electron charge carrier, or the momentum or energy state of the charge carrier.
- the molecular sensor circuit comprises more than two arms, for example, 3 arms (the first arm 115 , the second arm 116 , and the third arm 117 ).
- additional arms may also provide stabilization, impose a spatial orientation (such as to orient an active site), or otherwise reduce physical degrees of freedom or conformational entropy, which may improve sensing by reducing the variability in conduction that comes from the system having more accessible conformations.
- Such additional arms may be conductive, but they can also be insulating if they are present primarily to provide stability, orientation, or reduction in spatial degrees of freedom.
- Such additional arms may connect to the electrode, or to other portions of the structure, such as to a substrate supporting the electrodes.
- Such arms may connect to additional electrodes in a system comprising more than two electrodes, including the case of a system with a gate electrode, such as a buried gate electrode.
- Connection to a gate electrode may refer to connection to the conductive portion of the gate, or connection to the insulating layer that separates actual conductive gate from the circuit, or, in the case of a buried gate, the surface layer above the buried gate, such as the connection to the surface illustrated in FIG. 16 .
- the enzyme may be connected to the electrodes directly 120 , as an essential conduction path, without the use of arm molecules.
- groups on the enzyme directly couple to the electrodes.
- one wiring connection comprises direct coupling to the enzyme, the other via an arm molecule.
- a sensor comprising a directly wired enzyme as an essential conduction path may have its signal performance enhanced through various environmental factors.
- the choice of buffer, buffer additives, temperature and applied voltage may be modulated to improve the signal quality.
- enzymes may complex with various cofactors that modulate their kinetics, and the salt levels in the buffer also impact enzyme kinetics, as does temperature, these factors may be used to improve signaling performance.
- the overall ionic strength of the buffer solution defines the Debye length in the solution, that is the distance over which electric fields extend in solution, and can impact the extent to which current carriers passing through the enzyme are influenced by the charge distributions of the enzyme and substrate, and thus buffer ionic strength or total salt concentration is another means of influencing or enhancing the signaling.
- the divalent cation content of the buffer is known to influence enzyme activity, and the choice of divalent cation, for example from among Mg++, Mn++, Ni++, Zn++, Co++, Ca++, Cr++, and their concentration may be optimized to improve the signaling from a polymerase wired as an essential conduction path.
- the applied driving voltage may be optimized to improve the signaling from an enzyme wired as an essential conduction path. Based on energy barriers within the enzyme, certain voltages may lead to improved signaling performance.
- various embodiments may also have a gate electrode, such as a buried gate below the lower substrate indicated in FIG. 3 , such that voltages applied to the gate electrode further modulate the signaling properties of the enzyme circuit.
- Certain embodiments may employ voltage spectroscopy, wherein the driving or gate voltages are swept through a range of values, and the signal of interest is in the response from this sweep, which contains information on the interaction between the enzyme and its substrates.
- the molecular circuit sensors of the present disclosure comprise the wiring of an enzyme with at least two points of electrical contact, so as to make the enzyme an essential conduction path, in contrast to the configuration of FIG. 2 .
- Two-point wiring of the enzyme may be combined with a conjugation 125 to one or more molecular arms 127 , as shown in FIGS. 10 and 11 .
- the current can be both driven through the enzyme, for sensing, and the enzyme can also modulate current through the other molecular wire, as an additional sensing mode.
- these conduction modes are monitored by a single electrode pair 130 , and combine to produce a single current, whereas in FIG.
- the senor may comprise an enzyme 126 wired up with two or more points of contact as a conduction path, in conjunction with additional sensor configuration features. Wiring the enzyme at two points, with input and output electrical contacts, can provide enhanced signaling. Other possible and non-limiting configurations are illustrated in FIGS. 10 and 11 .
- a molecular circuit sensor comprises a polymerase enzyme.
- FIG. 12 shows a representative polymerase enzyme 150 , the Klenow Fragment of E. coli DNA Polymerase I.
- FIG. 12 illustrates a ribbon diagram of the enzyme structure, from two different views, with the enzyme engaged with a double-stranded DNA template 170 .
- the enzyme primary structure is a single amino acid sequence of 605 amino acids.
- the secondary structure and tertiary structure of the enzyme are depicted in FIG. 12 .
- This figure shows the structural elements of the enzyme. In particular, there are 28 distinct alpha-helix elements 160 , and two major beta-sheet elements 165 , separated by short flexible loop segments 155 .
- Such structural elements are similarly present in other types of polymerases and other enzyme proteins in general. In the course of enzyme activity, these structural features engage in electrical, chemical, mechanical and conformational perturbations, and wiring to these features within an electrical circuit can transduce these perturbations into measured signals.
- FIG. 13 shows an embodiment where the polymerase 177 is wired as an essential conduction path, and specifically wired to the ends of a long alpha-helix 180 that passes through the center of the enzyme.
- This alpha-helix was chosen because it passes very near to the active pocket of the polymerase, and therefore can provide for enhanced current sensing of the polymerase activity as it binds to a primed strand and extends the primer through incorporation of dNTPs.
- Other alpha-helices in the structure will provide other sensing opportunities, and other embodiments comprise wiring to such alpha-helix structures, or the beta-sheet structures, or other such structures occurring in series.
- the arms may comprise double stranded oligonucleotides terminated with a maleimide, which couples to a cysteine genetically engineered into a precise location in a mutant form of the polymerase.
- the arms comprise a protein alpha-helix terminated with a maleimide which couples such a cysteine.
- cysteine (C) placed at the conjugation points indicated in FIG. 3 , which arise from replacing the glutamine (Q) at amino acid position 548 by C, and replacing the serine (S) at amino acid position 508 by C, and these two locations lie just outside and bracket a single long (37 amino acid) alpha-helix that extends from amino acid position 514 to 547.
- the mutant polymerase further has the single native C at amino acid position 584 replaced by a non-cysteine, such as S, so as to provide exactly the two sites for coupling of the maleimide terminated arms, via the well-known maleimide-cysteine conjugation.
- a non-cysteine such as S
- Making such amino acid substitutions to introduce cysteines should be done in a manner that does not alter highly conserved amino acids (as conserved in comparison to other polymerases), does not alter amino acids in the alpha-helix or other structural elements that are the target of the wiring, does not alter amino acids directly participating in critical enzyme function, such as those that interact directly with the structure of the substrate binding pocket, the DNA substrate or the dNTP substrates. Similar selection principles apply to other enzymes as well when mutating in cysteine as a maleimide conjugation point.
- FIG. 14 illustrates an alternative embodiment where the mutant polymerase 177 of FIG. 13 is directly conjugated 185 to the electrodes 187 , coupling to the internal alpha-helix, without the use of connecting arms.
- This coupling can be achieved, for example, by utilizing gold electrodes, and a gold-binding peptide (GBP) with a maleimide terminus, such that the maleimide conjugates the GBP to the mutant polymerase at the cysteine sites described above, and the GBP conjugates to the gold electrode, thereby wiring in the polymerase via these two cysteine sites.
- GBP gold-binding peptide
- Other embodiments of direct maleimide-mediated conjugations to the electrodes are enabled by using conjugating groups having the form X-maleimide bonded to the cysteines on the polymerase, such that X is a group that then binds to the electrode surface.
- FIG. 15 illustrates an alternative embodiment, where the mutant polymerase 177 of FIG. 13 is wired to the electrodes 212 using connecting arms 210 through an alpha-helix 200 adjacent to the binding cleft 205 of the polymerase.
- the connecting arms are wired to two points 215 on the polymerase. In embodiments, these two points have the ability to move relative to each other, thereby allowing for changes in conductivity and enhanced signaling.
- FIG. 16 illustrates an embodiment in which multiple arms 190 are used to wire up the polymerase 195 as an essential conducting path, as well as to stabilize its position and orientation relative to the electrodes and substrate.
- the lower pair of arms indicated can be either conducting or insulating, in accordance with various embodiments.
- a circuit comprises an enzyme wired in as an essential conduction path.
- the circuit may comprise first and second wiring points, connecting to a first and a second electrode such as a positive electrode and a negative electrode.
- the circuit may further comprise at least one arm molecule having two ends, one end bonded to the enzyme and the other end bonded to at least one of the electrodes, wherein the at least one arm molecule acts as an electrical wire between the enzyme molecule and at least one of the electrodes.
- an arm molecule may be selected from the group consisting of a double stranded oligonucleotide, a peptide nucleic acid (PNA) duplex, a PNA-DNA hybrid duplex, a protein alpha-helix, a graphene-like nanoribbon, a natural polymer, a synthetic organic molecule e.g. a synthetic polymer, and an antibody Fab domain.
- the enzyme is wired directly to the electrodes without the use of any arm molecules.
- the wiring may be to an internal structural element in the enzyme, such as an alpha-helix, or a beta sheet, or multiple such elements in series.
- a circuit comprises an enzyme wired at points that undergo relative conformational change.
- arms comprise molecules that have a tension dependent conductivity.
- arm molecules may have torsion or twist dependent conductivity. Additional wiring points may be used to couple the enzyme at additional sites.
- a circuit comprises a polymerase enzyme, such as for example, E. coli Pol I Klenow Fragment, wherein the wiring is to the major alpha-helix extending between amino acids at position 514 and 547.
- a polymerase enzyme such as for example, E. coli Pol I Klenow Fragment
- Such connection may rely on the placement of genetically engineered cysteines at or near these amino acid positions.
- Circuits comprising a polymerase may be used to sense sequence information from a DNA template processed by the polymerase.
- a circuit in accordance to various embodiments of the present disclosure may be exposed to a solution containing primed single stranded DNA, and/or dNTPs, wherein the current through the circuit is measured as the polymerase engages and extends a template, and the resulting signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
- connection between the enzyme molecule and at least one of the positive electrode and negative electrode may comprise any one of: a native cysteine, a genetically engineered cysteine, a genetically engineered amino acid with a conjugation residue, or a genetically engineered peptide domain comprising a peptide that has a conjugation partner.
- the wiring is to points on the thumb and finger domain of the enzyme, where such points undergo relative motion in excess of 1 nm as the polymerase processes a DNA template.
- the polymerase is engineered to have extended domains that produce a greater range of relative motion as the polymerase processes a DNA template. For example, conformational changes in an enzyme may be accentuated by extending various domains in the enzyme.
- a polymerase enzyme may also be engineered to have additional charge groups that variably influence the internal conduction path as the enzyme processes a DNA template.
- a circuit is exposed to a solution comprising modified dNTPs that variably influence the internal conduction path as the enzyme processes a DNA or RNA template.
- the polymerase enzyme is a genetically modified form of one of: E. coli. Pol I polymerase, Bst polymerase, Taq polymerase, Phi29 polymerase, T7 polymerase, and reverse transcriptase.
- a circuit is exposed to one or more of the conditions of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode.
- the polymerase enzyme comprises a reverse transcriptase or genetically modified reverse transcriptase, capable of directly acting on an RNA template.
- a reverse transcriptase in these circuits has the benefit that the reverse transcriptase can directly process an RNA template, and therefore provide a means for directly sequencing RNA molecules.
- this reverse transcriptase could be any monomeric reverse transcriptase or a genetically modified form thereof, such as Moloney murine leukemia virus reverse transcriptase, porcine endogenous retrovirus reverse transcriptase, bovine leukemia virus reverse transcriptase, mouse mammary tumor virus reverse transcriptase, or a heterodimeric reverse transcriptase such as human immunodeficiency virus reverse transcriptase or Rous sarcoma virus reverse transcriptase.
- a monomeric reverse transcriptase such as Moloney murine leukemia virus reverse transcriptase, porcine endogenous retrovirus reverse transcriptase, bovine leukemia virus reverse transcriptase, mouse mammary tumor virus reverse transcriptase, or a heterodimeric reverse transcriptase such as human immunodeficiency virus reverse transcriptase or Rous sarcoma virus reverse transcriptase.
- a method of sequencing a DNA molecule comprises: providing an enzyme-based molecular circuit having spaced-apart positive and negative electrodes and a polymerase enzyme molecule connected to both the positive and negative electrodes to form a conductive pathway between the electrodes; initiating at least one of a voltage or a current through the circuit; exposing the circuit to a solution containing primed single stranded DNA and/or dNTPs; and measuring electrical signals through the circuit as the polymerase engages and extends a template, wherein the electrical signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
- a method of molecular detection comprises: (a) providing an enzyme-based molecular circuit having spaced-apart positive and negative electrodes, a polymerase enzyme molecule connected to both the positive and negative electrodes to form a conductive pathway between the electrodes, and a gate electrode; (b) initiating at least one of a voltage or a current through the circuit; (c) exposing the circuit to at least one of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode; and (d) measuring an electrical change in the circuit.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nanotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Electrochemistry (AREA)
- Cell Biology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
Abstract
Description
- This application is a continuation of U.S. application Ser. No. 16/015,028 filed Jun. 21, 2018 and entitled “Enzymatic Circuits for Molecular Sensors.” The '028 Application is a continuation of PCT Application No. PCT/US18/29382, filed on Apr. 25, 2018 entitled “Enzymatic Circuits for Molecular Sensors,” which claims priority to and the benefit of U.S. Provisional Patent Application Ser. No. 62/489,881 filed Apr. 25, 2017 and entitled “Enzymatic Circuits for Molecular Sensors,” the disclosures of which are incorporated herein by reference in their entirety.
- The present disclosure is generally directed to molecular sensors and more particularly to molecular sensors in which an enzyme closes the circuit between two electrodes.
- The broad field of molecular electronics was introduced in the 1970's by Aviram and Ratner. Molecular electronics achieves the ultimate scaling down of electrical circuits by using single molecules as circuit components. Molecular circuits comprising single molecule components can function diversely as switches, rectifiers, actuators and sensors, depending on the nature of the molecule. Of particular interest is the application of such circuits as sensors, where molecular interactions provide a basis for single molecule sensing. In particular, informative current changes could include an increase, or decrease, a pulse, or other time variation in the current.
- Notwithstanding the achievements in the field of molecular electronics, new molecular circuits that can function as molecular sensors are still needed. In particular, the need still exists for improved single molecule systems that can yield molecular information with greater signal-to-noise ratios such that signals truly indicative of molecular interactions are distinguishable from non-informative noise.
- In various embodiments, single molecule enzyme-based circuits are disclosed wherein a single enzyme molecule is directly connected to a positive and negative electrode to form the circuit. These circuits are capable of yielding highly informative signals of enzyme activity. These improved signals have greater signal-to-noise levels such that the signals are more distinguishable from noise, and these improved signals include features that carry detailed information about the engagement between enzyme and the target substrate.
- In various embodiments, a molecular sensor comprises an enzyme-based molecular circuit (conductive pathway) such as described herein. Such a sensor having a polymerase enzyme is usable to sense sequence information from a DNA template processed by the polymerase.
- In various embodiments of the present disclosure, a molecular circuit is disclosed. The circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes.
- In various aspects, the enzyme of the circuit may comprise a first wiring point connected to the positive electrode and a second wiring point connected to the negative electrode.
- In various aspects, the circuit may further comprise at least one arm molecule having first and second ends, the first end bonded to the enzyme and the second end bonded to at least one of the electrodes, wherein the at least one arm molecule acts as an electrical wire between the enzyme and at least one of the electrodes.
- In various aspects, the at least one arm molecule may be selected from the group consisting of a double stranded oligonucleotide, a peptide nucleic acid duplex, a peptide nucleic acid-DNA hybrid duplex, a protein alpha-helix, a graphene-like nanoribbon, a natural polymer, a synthetic polymer, and an antibody Fab domain.
- In various aspects, at least one of the electrodes is connected to an internal structural element of the enzyme.
- In various aspects, the internal structural element may be selected from the group consisting of an alpha-helix, a beta-sheet, and a multiple of such elements in series.
- In various aspects, at least one of the electrodes may be connected to the enzyme at a location of the enzyme capable of undergoing a conformational change.
- In various aspects, at least one arm molecule may comprise a molecule having tension, twist or torsion dependent conductivity.
- In various aspects, the enzyme may comprise a polymerase.
- In various aspects, the polymerase comprises E. coli Pol I Klenow Fragment.
- In various aspects, the polymerase comprises a reverse transcriptase.
- In various aspects, the polymerase comprises a genetically modified reverse transcriptase.
- In various aspects, a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme comprising E. coli Pol I Klenow Fragment connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the polymerase at connection points within the major alpha-helix of the polymerase extending between amino acids at position 514 and 547.
- In various aspects, a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the sensor is usable to sense sequence information from a DNA template processed by the polymerase.
- In various aspects, a molecular sensor comprises a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the polymerase at connection points on the thumb and finger domains of the polymerase, and wherein such points undergo relative motion in excess of 1 nanometer as the polymerase processes a DNA template.
- In various aspects, the polymerase in this sensor is engineered to have extended domains which produce a greater range of relative motion as the polymerase processes a DNA template.
- In various aspects, the polymerase in this sensor is engineered to have additional charge groups that variably influence the internal conduction path as the enzyme processes a DNA template.
- In various aspects, the polymerase in this circuit is a genetically modified form of E. coli. Pol I, Bst, Taq, Phi29, or T7 DNA polymerases, or a genetically modified reverse transcriptase.
- In various aspects, a molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes, wherein the positive electrode and the negative electrode each connect to the enzyme at connection points in the enzyme comprising at least one of a native cysteine, a genetically engineered cysteine, a genetically engineered amino acid with a conjugation residue, or a genetically engineered peptide domain comprising a peptide that has a conjugation partner.
- In various aspects, this circuit further comprises a gate electrode.
- In various embodiments, a method of sequencing a DNA molecule is disclosed. The method comprises: providing a circuit further comprising a positive electrode; a negative electrode spaced apart from the positive electrode; and a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes; initiating at least one of a voltage or a current through the circuit; exposing the circuit to a solution containing primed single stranded DNA and/or dNTPs; and measuring electrical signals through the circuit as the polymerase engages and extends a template, wherein the electrical signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
- In various embodiments, a method of molecular detection is disclosed. The method comprises, providing a circuit further comprising: a positive electrode; a negative electrode spaced apart from the positive electrode; a polymerase enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes and a gate electrode; initiating at least one of a voltage or a current through the circuit; exposing the circuit to at least one of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode; and measuring an electrical change in the circuit.
- The subject matter of the present disclosure is particularly pointed out and distinctly claimed in the concluding portion of the specification. A more complete understanding of the present disclosure, however, may best be obtained by referring to the detailed description and claims when considered in connection with the drawing figures:
-
FIG. 1 illustrates the general concept of a molecular electronic circuit; -
FIG. 2 illustrates the general concept of engaging an enzyme to a molecular electronic circuit, such as to act as a sensor of enzyme activity with its target; -
FIG. 3 illustrates an enzyme that is wired directly into the current path, in accordance with various embodiments; -
FIG. 4 illustrates an enzyme that is wired directly into the current path, with the connection made to an internal alpha-helix structure within the enzyme, in accordance with various embodiments; -
FIG. 5 illustrates an enzyme that is wired directly into the current path, with the connection made to a series of two or more internal alpha-helix structures in series within the enzyme, in accordance with various embodiments; -
FIG. 6 illustrates an enzyme that is wired directly into the current path, with the connection made to an internal beta-sheet structure within the enzyme, in accordance with various embodiments; -
FIG. 7 illustrates an enzyme that is wired directly into the current path, such that connections are made to points of conformational change in the enzyme, to induce tension changes into the circuit during enzyme activity; -
FIG. 8 illustrates an enzyme that is wired directly into the current path, with additional connections made to stabilize the position of the enzyme; -
FIG. 9 illustrates a schematic of an enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein the enzyme directly couples to the electrodes without the use of arm molecules; -
FIG. 10 illustrates a schematic of an enzyme directly wired by two points of contact into a circuit, as well as also having a one-point conjugation to a molecular wire, utilizing one pair of electrodes to measure the combined conduction, in accordance with various embodiments; -
FIG. 11 illustrates a schematic of an enzyme directly wired by two points of contact into a circuit, as well as also having a one-point conjugation to a molecular wire, utilizing two pairs of electrodes to measure these two modes of conduction independently, in accordance with various embodiments; -
FIG. 12 illustrates a protein structure view of the E. coli Pol I Klenow Fragment Polymerase enzyme, illustrating the presence of alpha-helix, beta-sheet, and connecting loop structures; -
FIG. 13 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein a specific alpha-helix is used for the contacts, and molecular arms provide coupling to the electrodes; -
FIG. 14 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein a specific alpha-helix is used for the contacts, and the polymerase directly couples to the electrodes without the use of arm molecules; -
FIG. 15 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, in accordance with various embodiments, wherein arms are wired to the points that undergo relative motion when the finger and thumb domains change relative conformation; and -
FIG. 16 illustrates a schematic of a polymerase enzyme directly wired into the current path of a circuit, and where additional connecting arms are wired to provide stabilization and fixed spatial orientation. - The detailed description of exemplary embodiments herein makes reference to the accompanying drawings, which show exemplary embodiments by way of illustration and their best mode. While these exemplary embodiments are described in sufficient detail to enable those skilled in the art to practice the inventions detailed herein, it should be understood that other embodiments may be realized and that logical, chemical, and mechanical changes may be made without departing from the spirit and scope of the inventions. Thus, the detailed description herein is presented for purposes of illustration only and not of limitation. For example, unless otherwise noted, the steps recited in any of the method or process descriptions may be executed in any order and are not necessarily limited to the order presented. Furthermore, any reference to singular includes plural embodiments, and any reference to more than one component or step may include a singular embodiment or step. Also, any reference to attached, fixed, connected or the like may include permanent, removable, temporary, partial, full and/or any other possible attachment option. Additionally, any reference to without contact (or similar phrases) may also include reduced contact or minimal contact.
- In various embodiments of the present disclosure, a molecular circuit is disclosed. The molecular circuit comprises: a positive electrode; a negative electrode spaced apart from the positive electrode; and an enzyme connected to both the positive and negative electrodes to form a conductive pathway between the positive and negative electrodes. In various examples, the enzyme comprises a first wiring point connected to the positive electrode and a second wiring point connected to the negative electrode.
- As used herein, the term “enzyme” means a molecule that acts to transform another molecule, by engaging with a variety of substrate molecules. Such transformation could include chemical modification, or conformational modification. Common biological enzyme classes are polymerases, ligases, nucleases, kinases, transferases, as well as genetically modified forms of these molecules. Polymerases herein include reverse transcriptases and any genetically modified reverse transcriptase, capable of directly acting on an RNA template. Enzymes are most commonly proteins, but may be composed of multiple amino acid chains, and may also be complexed with other types of molecules, such as RNA in the case of the ribosome enzyme.
- As used herein, the term “substrate” for an enzyme refers to any of the molecules that the enzyme specifically engages with in the course of performing a transformation. For example, in the specific case of a DNA polymerase, the substrate consists of both a template DNA and dNTPs. In addition to the substrates of the enzyme, the enzyme may also complex with various co-factors that moderate its function or kinetics. For example, in the case of DNA polymerase, divalent cations such as Mg++ are often essential cofactors, but not considered as substrates.
- As used herein, the term “dNTP” or “dNTPs” refers to any of the deoxynucleotide triphosphates involved in polymerase-based DNA synthesis, or that can be engaged for such DNA synthesis, including both native and modified forms of such molecules.
- As used herein, the term “buffer” for an enzyme refers to a solution in which the enzyme is viable and functional, and typically containing the substrates and co-factors needed for enzyme activity. Such an enzyme buffer may typically comprise salts, detergents, and surfactants, singly or in various combinations, as well as specific cofactors, such as magnesium or other divalent cations for a polymerase enzyme, along with the substrates, such as DNA and dNTPs for a polymerase enzyme. Such a buffer herein may have its composition modified from standard forms, such as to enhance signal properties in a sensor exposed to the buffer.
- As used herein, the term “electrode” means any structure that can act as an efficient source or sink of charge carriers. Most commonly these would be metal or semiconductor structures, such as those used in electronic circuits. A pair of spaced apart electrodes herein may comprise a source and drain electrode pair. In various embodiments of the present disclosure, a binding probe-based molecular circuit may further comprise a gate electrode. When present, a gate electrode is used to apply a voltage rather than transfer charge carriers. Thus it supports accumulation of charge carriers to produce a local electric field, but is not intended to pass current. A gate electrode will be electrically isolated from the primary conduction paths of the circuit by some form of insulating layer or material.
- As used herein, the term “conjugation” means any of the wide variety of means of physically attaching one molecule to another, or to a surface or particle. Such methods typically involve forming covalent or non-covalent chemical bonds, but may also rely on protein-protein interactions, protein-metal interactions, or chemical or physical adsorption via intermolecular (Van der Waals) forces. There is a large variety of such methods know to those skilled in the art of conjugation chemistry. Common conjugation methods relevant to preferred embodiments herein include thiol-metal bonds, maleimide-cysteine bonds, material binding peptides such as gold binding peptides, and click chemistries.
- As used herein, the term “initiating,” in the context of an electrical parameter, is intended to be broader than the concept of “applying” an electrical value. For example, an electrical current may be initiated in a circuit. Such initiating of a current may be the result of applying a voltage to the circuit, but may be from other actions to the circuit besides applying a voltage. Further, a voltage may be initiated in a circuit. Such initiating of a voltage may be the result of applying a current to the circuit, but may be from other actions to the circuit besides applying an electrical current. In other examples, a voltage or a current may be initiated in one portion of a circuit as the result of applying a voltage or a current to the overall circuit. In a non-limiting example, a flow of electrons initiated from a negative to a positive electrode in a circuit of the present disclosure may be controlled by the voltage applied to the gate electrode of the circuit.
- In various embodiments of the present disclosure, a molecular sensor comprises an enzyme connected to both a positive and a negative electrode to complete a circuit. Interactions of the enzyme with various substrates are detectable as changes in the current or other electrical parameter measured across the circuit. The present molecular sensor differs from the general concept of a molecular electronic circuit in that the enzyme is directly “wired” to both the positive and negative electrodes rather than bonded to a molecular bridge molecule that spans the gap between the electrodes to complete a circuit.
- In various aspects of the disclosure, at least one of a voltage or a current is initiated in an enzyme-based molecular circuit. When a target interacts with the enzyme, electrical changes in the circuit are sensed. These electrical changes, or informative electrical signals, may include current, voltage, impedance, conductivity, resistance, capacitance, or the like. In some examples, a voltage is initiated in the circuit and then changes in the current through the circuit are measured as substrates interact with the enzyme. In other examples, a current is initiated in the circuit, and changes to voltage in the circuit are measured as substrates interact with the enzyme. In other examples, impedance, conductivity, or resistance is measured. In examples wherein the circuit further comprises a gate electrode, such as positioned underneath the gap between the positive and negative electrodes, at least one of a voltage or current may be applied to the gate electrode, and voltage, current, impedance, conductivity, resistance, or other electrical change in the circuit may be measured as substrates interact with the enzyme.
-
FIG. 1 illustrates the general concept of a molecular electronic circuit having abridge molecule 10 attached to and bridging thegap 12 betweenelectrodes 15, as well as some type ofconjugation group 20 or other mechanism that binds the molecule to the electrodes (depicted as small shaded squares).FIG. 1 further illustrates that a current, (i), may pass through this molecule and be measured versus time, (t), as shown in theinset plot 25. -
FIG. 2 illustrates a molecular electronic sensor in which anenzyme 30 is conjugated to themolecular bridge component 31 spanning theelectrodes 32, wherein monitoring the current provides a sensor for the enzyme engaging with and processing itstarget substrate 35 when exposed to a suitable buffer solution. In such a sensor system, the local charge perturbations that result from the target substrate engaging with the enzyme perturb charge transport through the primary bridge component, and are thus registered as a change in conductivity or current versus time, as indicated by the step-up change in the current (i) vs. time (t) current plot inset 38 inFIG. 2 . - In contrast to the general molecular circuit concept as depicted in
FIGS. 1 and 2 , in various embodiments of the present disclosure a molecular sensor comprises a single enzyme molecule directly wired into the circuit path, such that all electrical current passing through the molecular circuit must flow through the enzyme. Thus the enzyme is an essential conduction path in the circuit, like an electronic component on a circuit board. The present concept is illustrated generally inFIG. 3 , which shows anenzyme 42 connected betweenmolecular arms 40. By forcing all current in the circuit to pass through the enzyme, the current carriers are forced to pass closer to the precise location of electrochemical interactions between the enzyme andtarget substrate 45, thereby causing such interactions to have greater impact on the current carriers, and, in turn making the overall current more sensitive to the details of these interactions. This is illustrated schematically by the current versus time, (i vs. t),plot inset 50 inFIG. 3 , wherein the current step is shown to be much larger than that produced by the configuration ofFIG. 2 , and also includes additional features not present in a current versus time plot such as depicted inFIG. 2 . The higher current step provides improved signaling. Related methods and preferred embodiments herein promote improved signaling of enzyme-based molecular sensors. Further, the configuration of the enzyme as an essential conduction path is fundamentally different from the common configuration ofFIG. 2 , in which there are many conduction paths that do not pass through the enzyme, and where potentially none of the charge carriers actually traverse the enzyme, and where there is no means provided to direct charge carriers to pass near key active sites within the enzyme. - In various embodiments, the enzyme may be coupled to both positive and negative electrodes at two or more points, such as to ensure that charge carriers traversing the molecular structure pass into and out of the enzyme.
- As shown in the embodiment of
FIG. 3 , two molecular arms are conjugated to the enzyme to provide physical anchors and entry and exit paths for the current through the enzyme. Such arms may comprise any convenient molecule that provides a conducting connection or semi-conducting connection between the enzyme and the electrodes. Further, molecular arms may provide spanning length extensions, to help span alarger electrode gap 55 that is wider than the 3D structure of the enzyme. Such arms may also provide the advantage of keeping the enzyme away from contacting theelectrodes 65 where unfavorable or damaging interactions may occur with the electrodes, such as a denaturing adsorption to the electrode. Such arms may also provide for more compatible or efficient coupling to the electrodes, such as by coupling to the electrodes via chemical groups that are not readily found or made available on the enzyme. For example, in one specific embodiment, the electrode comprises gold and the molecular arm includes a thiol group, such that the arm couples to the gold electrode via well-known thiol-gold binding. Thus the molecular arm accomplishes the binding while the enzyme may not have such available thiol groups. Or, in another embodiment, the arms may present a click-chemistry binding group, for coupling to electrodes that are derivatized with the cognate binding partners for the click chemistry. - In various embodiments, molecular arms comprise some form of
conjugation 60 to the enzyme, as well as their conjugations or couplings to the electrodes. Many conjugation chemistries can be employed for this purpose. In a non-limiting example, such conjugation comprises chemical crosslinking, which can preferentially couple suitable chemical groups on the arms to amino acid residues on the enzyme. In various embodiments, a maleimide group on the arm couples to a surface cysteine on the enzyme. In other aspects, genetically modified versions of an enzyme may be created and employed, such as enzymes comprising specific amino acids or protein domains engineered into their amino acid structure that provide specific conjugation sites. For example, cysteine amino acids engineered at specific sites on the enzyme provide for the attachment point of arms that present a maleimide group. Two such cysteine sites conjugate to two maleimide derivatized arms to produce a configuration such as that shown inFIG. 3 . In this case, one or more native cysteines that would provide competing arm binding sites may be “engineered out” of the amino acid sequence. If not all such sites can be removed, it is possible to use various purification methods from synthetic chemistry to isolate desired enzyme-arm conjugates from unwanted configurations. In other variations, genetic methods are used to engineer into the amino acid sequence of the enzyme amino acids comprising residues that uniquely conjugate to a cognate group on the arms. This variation includes cases where non-standard amino acids are employed, such as amino acids modified to present a click-chemistry group, via protein expression systems that use a modified genetic code and modified transfer RNAs to put non-native amino acids at specific sequence sites in an expressed enzyme protein. - In other embodiments, a peptide domain that specifically binds with a cognate group on the arms is engineered into the sequence of a protein enzyme. In one such embodiment, a peptide that is an antigen to an antibody is engineered into the enzyme, and the Fab binding domain of the antibody is used on the arms. One such embodiment is to use the FLAG peptide motif DYKDD, and any suitable ANTI-FLAG Fab domain. Any other peptide antigens and their cognate Fab domains can similarly be used to conjugate arms to specific sites in an engineered enzyme protein, by engineering the peptide antigen into the desired conjugation sites on the enzyme. Other such peptide domains make use of the SPY-TAG/SPY-CATCHER protein-protein binding system, by engineering either the SPY-TAG domain or the SPY-CATCHER domain into the enzyme protein, and placing the cognate domain in the arms. When engineering such peptide binding domains into the enzyme, another embodiment is to add short linker peptide sequences flanking the target peptide, to enhance the availability of the domain for binding. Such short linkers may comprise short glycine and serine rich linkers, as are known to those skilled in the art of protein engineering, including, but not limited to, the linker amino acid sequences G, GS, GSG, GGSG, etc.
- In various examples, the arm molecules comprise any molecules that provide for conduction of charge carriers into and out of the enzyme. In certain embodiments, such arms comprise molecular wires from the many forms known in field of molecular electronics, functionalized with suitable conjugation and binding groups for wiring to electrodes and enzyme. In various aspects, such arms may comprise single stranded DNA, double stranded DNA, peptides, peptide alpha-helices, antibodies, Fab domains of antibodies, carbon nanotubes, graphene nanoribbons, natural polymers, synthetic polymers, other organic molecules with p-orbitals for electron delocalization, or metal or semiconductor nanorods or nanoparticles. In further embodiments, the arms may comprise double stranded DNA with thiol-bearing groups at one end, and maleimide at the other end that couples to the enzyme, or a peptide alpha-helix with a cysteine or gold binding peptide at one termini, and a maleimide at the other end that couples to the enzyme, or a graphene nanoribbon with thiol-bearing groups at one end, and a maleimide bearing group at the other end that couples to the enzyme. In certain embodiments, the two arm molecules used to couple an enzyme to two electrodes are identical molecules, and in other embodiments, the two arm molecules are different molecules. In some examples, there may be a “positive electrode” arm and a “negative electrode” arm, providing for oriented binding of an enzyme to the corresponding “positive” and “negative” electrodes in
FIG. 3 . - In various embodiments, arm conjugation points connect directly to specific protein structural elements within the enzyme. A non-limiting example is illustrated in
FIG. 4 , where thearms 75 are shown wired directly to an alpha-helix structure 70 in theenzyme 72. Such structural elements provide preferential conduction paths through the enzyme. Direct wiring to natural conduction paths in the enzyme guide current closer to active regions of interest within the enzyme, such as substrate binding pockets, and may thereby provide for further enhanced current signals, or current signals that carry more information on enzyme-substrate interactions. For example, one embodiment is shown inFIG. 4 , where the arms wire directly to an alpha-helix that spans between two points on or near the surface of the enzyme. Another example is shown inFIG. 5 , where thearms 80 wire directly to two alpha-helices (the first alpha-helix 85 and the second alpha helix 87) that appear in series internally in the enzyme, with a single connectingloop 90 separating them. Yet another embodiment is shown inFIG. 6 , where thearms 95 wire directly to twopoints 98 on a beta-sheet 100 internal to theenzyme 102. - In general, a protein enzyme will have a 3D structure that includes well known secondary structural elements such as alpha-helices and beta-sheets. These are primarily hydrogen bonded structures that can provide discrete conduction paths through the body of the enzyme, to the extent that current carriers, such as electrons, may efficiently hop along such structures, or along the hydrogen bonds that define such structures, with less resistance than otherwise hopping or tunneling off such structures. These structures provide preferential conduction paths that will channel charge carriers, and by selecting such structures, charge is forced to pass close to active regions of the enzyme, and current-based sensing of the activity will be improved. Having the arms directly connected to such structures, or within a small number of amino acids of the termini of such structures, the current flowing along these desirable paths is maximized, and thus the desirable signals that come from the current along such paths is maximized. In this way, current going elsewhere within the enzyme is minimized, and thus the noise from probing these less informative regions is also minimized.
- In various examples, the wiring can be to such structures that appear in the enzyme “in series”, such as for example, two alpha-helices in series as indicated in
FIG. 5 , or a beta-sheet in series with an alpha-helix, or three successive alpha-helices. In general, each successive element in series appears in the enzyme primary amino acid sequence as separated from the previous element by a small number of amino acids, such 0, 1, 2, or up to approximately 10 amino acids, which typically form a connecting loop in the secondary structure. Wiring of elements in series may also be achieved by wiring to structures that are not contiguous in the primary amino acid sequence of the enzyme, but are nonetheless spatially contiguous and in conductive contact, and form a preferred conduction path, owing to hydrogen bonding, salt bridges, disulfide bridges, or other types of molecular interaction that establish secondary, tertiary or quaternary protein structure and that can provide a clearly defined and favorable conduction path from one structural element (beta-sheet, alpha-helix) to another. These structural elements of interest for wiring, either in isolation or in series, are most evident when examining the 3D structure of the proteins involved, as can be observed from the crystal structures, and in particular, by examination of the protein structures obtained by X-ray or NMR crystallography. This useful form of structural information is illustrated by the polymerase enzyme structure shown inFIG. 12 . - In other embodiments, the arms are wired to points on the enzyme that undergo conformation changes or relative motion during enzyme function, such as illustrated in
FIG. 7 . In this case, thearms 105 are wired to twopoints 110 that are indicated as having relative motion, as illustrated in theinset 108, during enzyme activity. This configuration can enhance signaling by several means. First, such motions can change the tension in the arms, and it is known that tension changes in molecules can change their conductivity, thus the motion may be transduced via tension into a change in conductivity of the arms, which consequently show up in the current signals. In this way, the current may contain information about the conformational changes in the enzyme. Second, similarly, this configuration can cause tension in the enzyme as it changes conformation, and thus alter conductivity of the enzyme. Since the enzyme is an essential current path, the conformation changes would transduce into current changes, and thereby represent conformation information in the sensing current. This configuration could also enhance signaling by altering the conformational changes of the enzyme, which may in some situations lead to an enhanced signal, for either a native enzyme, or one engineered to specifically benefit from such conformation-sensitive wiring. In one embodiment, an enzyme is engineered to have extended regions that undergo greater conformational change or relative motion (e.g. as demonstrated by extending the length of the two tips of the scissor-shaped enzyme indicated inFIG. 7 ), so as to enhance the range of motion, and therefore the range of tension changes in the arms and enzymes. - In other aspects, conformational changes in the enzyme, such as when induced binding occurs between the enzyme and a substrate, are translated into a twist, torque or rotation of at least one arm, and that twist, torsion or rotation alters the conductivity of the arm. One such example is an arm comprising an organic polymer further comprising polycyclic aromatic rings, such as polythiophene or polyphenylene, whereby previously lined up p-orbitals are rotated out of alignment by C—C bond rotation when the arm is twisted, torqued or rotated in response to an enzyme conformational change. When the arm is twisted, torqued or rotated, the electrons have impeded delocalization through the organic polymer. In certain embodiments, such impeded flow may act on only a subset of the charge carriers, depending on, for example, the polarization or other quantum state of the charge carrier, such as spin polarization of an electron charge carrier, or the momentum or energy state of the charge carrier.
- Another example is illustrated in
FIG. 8 , wherein the molecular sensor circuit comprises more than two arms, for example, 3 arms (thefirst arm 115, thesecond arm 116, and the third arm 117). The benefits to using additional enzyme wiring points and associated arms include addition of other desirable conduction paths through the enzyme, and increasing the overall conduction through the enzyme. Such additional arms may also provide stabilization, impose a spatial orientation (such as to orient an active site), or otherwise reduce physical degrees of freedom or conformational entropy, which may improve sensing by reducing the variability in conduction that comes from the system having more accessible conformations. Such additional arms may be conductive, but they can also be insulating if they are present primarily to provide stability, orientation, or reduction in spatial degrees of freedom. Such additional arms may connect to the electrode, or to other portions of the structure, such as to a substrate supporting the electrodes. Such arms may connect to additional electrodes in a system comprising more than two electrodes, including the case of a system with a gate electrode, such as a buried gate electrode. Connection to a gate electrode may refer to connection to the conductive portion of the gate, or connection to the insulating layer that separates actual conductive gate from the circuit, or, in the case of a buried gate, the surface layer above the buried gate, such as the connection to the surface illustrated inFIG. 16 . - As illustrated in
FIG. 9 , the enzyme may be connected to the electrodes directly 120, as an essential conduction path, without the use of arm molecules. In this case, groups on the enzyme directly couple to the electrodes. Or, in another embodiment, one wiring connection comprises direct coupling to the enzyme, the other via an arm molecule. The advantages of this arm-less configuration include minimizing the length of the conduction path, since the parts of the conduction path outside of the enzyme can be sources of unwanted noise, resistance or capacitance. The considerations above for the case of wiring with arms generally also apply to the special case of an arm-less configuration as well as the configuration of a single arm combined with direct enzyme coupling. Specifically, in embodiments lacking arms, the enzyme may still be wired via internal structures, or at points of conformational change. - A sensor comprising a directly wired enzyme as an essential conduction path may have its signal performance enhanced through various environmental factors. For example, the choice of buffer, buffer additives, temperature and applied voltage may be modulated to improve the signal quality. In particular, since enzymes may complex with various cofactors that modulate their kinetics, and the salt levels in the buffer also impact enzyme kinetics, as does temperature, these factors may be used to improve signaling performance. In addition, the overall ionic strength of the buffer solution defines the Debye length in the solution, that is the distance over which electric fields extend in solution, and can impact the extent to which current carriers passing through the enzyme are influenced by the charge distributions of the enzyme and substrate, and thus buffer ionic strength or total salt concentration is another means of influencing or enhancing the signaling. In embodiments utilizing a polymerase enzyme, the divalent cation content of the buffer is known to influence enzyme activity, and the choice of divalent cation, for example from among Mg++, Mn++, Ni++, Zn++, Co++, Ca++, Cr++, and their concentration may be optimized to improve the signaling from a polymerase wired as an essential conduction path.
- The applied driving voltage may be optimized to improve the signaling from an enzyme wired as an essential conduction path. Based on energy barriers within the enzyme, certain voltages may lead to improved signaling performance. In addition to an applied voltage, various embodiments may also have a gate electrode, such as a buried gate below the lower substrate indicated in
FIG. 3 , such that voltages applied to the gate electrode further modulate the signaling properties of the enzyme circuit. Certain embodiments may employ voltage spectroscopy, wherein the driving or gate voltages are swept through a range of values, and the signal of interest is in the response from this sweep, which contains information on the interaction between the enzyme and its substrates. - In general, the molecular circuit sensors of the present disclosure comprise the wiring of an enzyme with at least two points of electrical contact, so as to make the enzyme an essential conduction path, in contrast to the configuration of
FIG. 2 . Two-point wiring of the enzyme may be combined with aconjugation 125 to one or moremolecular arms 127, as shown inFIGS. 10 and 11 . In these embodiments, the current can be both driven through the enzyme, for sensing, and the enzyme can also modulate current through the other molecular wire, as an additional sensing mode. InFIG. 10 , these conduction modes are monitored by asingle electrode pair 130, and combine to produce a single current, whereas inFIG. 11 , these two conduction modes can be monitored by two separate electrode pairs (afirst electrode pair 135 and a second electrode pair 140), producing twocurrent measurements 145. In certain embodiments, the sensor may comprise anenzyme 126 wired up with two or more points of contact as a conduction path, in conjunction with additional sensor configuration features. Wiring the enzyme at two points, with input and output electrical contacts, can provide enhanced signaling. Other possible and non-limiting configurations are illustrated inFIGS. 10 and 11 . - In various embodiments, a molecular circuit sensor comprises a polymerase enzyme.
FIG. 12 shows arepresentative polymerase enzyme 150, the Klenow Fragment of E. coli DNA Polymerase I.FIG. 12 illustrates a ribbon diagram of the enzyme structure, from two different views, with the enzyme engaged with a double-strandedDNA template 170. The enzyme primary structure is a single amino acid sequence of 605 amino acids. The secondary structure and tertiary structure of the enzyme are depicted inFIG. 12 . This figure shows the structural elements of the enzyme. In particular, there are 28 distinct alpha-helix elements 160, and two major beta-sheet elements 165, separated by shortflexible loop segments 155. Such structural elements are similarly present in other types of polymerases and other enzyme proteins in general. In the course of enzyme activity, these structural features engage in electrical, chemical, mechanical and conformational perturbations, and wiring to these features within an electrical circuit can transduce these perturbations into measured signals. -
FIG. 13 shows an embodiment where thepolymerase 177 is wired as an essential conduction path, and specifically wired to the ends of a long alpha-helix 180 that passes through the center of the enzyme. This alpha-helix was chosen because it passes very near to the active pocket of the polymerase, and therefore can provide for enhanced current sensing of the polymerase activity as it binds to a primed strand and extends the primer through incorporation of dNTPs. Other alpha-helices in the structure will provide other sensing opportunities, and other embodiments comprise wiring to such alpha-helix structures, or the beta-sheet structures, or other such structures occurring in series. Thearms 175 indicated inFIG. 13 may comprise double stranded oligonucleotides terminated with a maleimide, which couples to a cysteine genetically engineered into a precise location in a mutant form of the polymerase. In another embodiment, the arms comprise a protein alpha-helix terminated with a maleimide which couples such a cysteine. One specific embodiment of such a mutant polymerase includes cysteine (C) placed at the conjugation points indicated inFIG. 3 , which arise from replacing the glutamine (Q) at amino acid position 548 by C, and replacing the serine (S) at amino acid position 508 by C, and these two locations lie just outside and bracket a single long (37 amino acid) alpha-helix that extends from amino acid position 514 to 547. In certain embodiments, the mutant polymerase further has the single native C at amino acid position 584 replaced by a non-cysteine, such as S, so as to provide exactly the two sites for coupling of the maleimide terminated arms, via the well-known maleimide-cysteine conjugation. Making such amino acid substitutions to introduce cysteines should be done in a manner that does not alter highly conserved amino acids (as conserved in comparison to other polymerases), does not alter amino acids in the alpha-helix or other structural elements that are the target of the wiring, does not alter amino acids directly participating in critical enzyme function, such as those that interact directly with the structure of the substrate binding pocket, the DNA substrate or the dNTP substrates. Similar selection principles apply to other enzymes as well when mutating in cysteine as a maleimide conjugation point. -
FIG. 14 illustrates an alternative embodiment where themutant polymerase 177 ofFIG. 13 is directly conjugated 185 to theelectrodes 187, coupling to the internal alpha-helix, without the use of connecting arms. This coupling can be achieved, for example, by utilizing gold electrodes, and a gold-binding peptide (GBP) with a maleimide terminus, such that the maleimide conjugates the GBP to the mutant polymerase at the cysteine sites described above, and the GBP conjugates to the gold electrode, thereby wiring in the polymerase via these two cysteine sites. Other embodiments of direct maleimide-mediated conjugations to the electrodes are enabled by using conjugating groups having the form X-maleimide bonded to the cysteines on the polymerase, such that X is a group that then binds to the electrode surface. -
FIG. 15 illustrates an alternative embodiment, where themutant polymerase 177 ofFIG. 13 is wired to theelectrodes 212 using connectingarms 210 through an alpha-helix 200 adjacent to thebinding cleft 205 of the polymerase. The connecting arms are wired to twopoints 215 on the polymerase. In embodiments, these two points have the ability to move relative to each other, thereby allowing for changes in conductivity and enhanced signaling. -
FIG. 16 illustrates an embodiment in whichmultiple arms 190 are used to wire up thepolymerase 195 as an essential conducting path, as well as to stabilize its position and orientation relative to the electrodes and substrate. The lower pair of arms indicated can be either conducting or insulating, in accordance with various embodiments. - In various embodiments, a circuit comprises an enzyme wired in as an essential conduction path. The circuit may comprise first and second wiring points, connecting to a first and a second electrode such as a positive electrode and a negative electrode.
- In various embodiments, the circuit may further comprise at least one arm molecule having two ends, one end bonded to the enzyme and the other end bonded to at least one of the electrodes, wherein the at least one arm molecule acts as an electrical wire between the enzyme molecule and at least one of the electrodes. Such an arm molecule may be selected from the group consisting of a double stranded oligonucleotide, a peptide nucleic acid (PNA) duplex, a PNA-DNA hybrid duplex, a protein alpha-helix, a graphene-like nanoribbon, a natural polymer, a synthetic organic molecule e.g. a synthetic polymer, and an antibody Fab domain. In other examples, the enzyme is wired directly to the electrodes without the use of any arm molecules. The wiring may be to an internal structural element in the enzyme, such as an alpha-helix, or a beta sheet, or multiple such elements in series.
- In various embodiments, a circuit comprises an enzyme wired at points that undergo relative conformational change. In certain aspects, arms comprise molecules that have a tension dependent conductivity. In other examples, arm molecules may have torsion or twist dependent conductivity. Additional wiring points may be used to couple the enzyme at additional sites.
- In various embodiments, a circuit comprises a polymerase enzyme, such as for example, E. coli Pol I Klenow Fragment, wherein the wiring is to the major alpha-helix extending between amino acids at position 514 and 547. Such connection may rely on the placement of genetically engineered cysteines at or near these amino acid positions. Circuits comprising a polymerase may be used to sense sequence information from a DNA template processed by the polymerase.
- A circuit in accordance to various embodiments of the present disclosure may be exposed to a solution containing primed single stranded DNA, and/or dNTPs, wherein the current through the circuit is measured as the polymerase engages and extends a template, and the resulting signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
- The connection between the enzyme molecule and at least one of the positive electrode and negative electrode may comprise any one of: a native cysteine, a genetically engineered cysteine, a genetically engineered amino acid with a conjugation residue, or a genetically engineered peptide domain comprising a peptide that has a conjugation partner. In certain aspects, the wiring is to points on the thumb and finger domain of the enzyme, where such points undergo relative motion in excess of 1 nm as the polymerase processes a DNA template. In other aspects, the polymerase is engineered to have extended domains that produce a greater range of relative motion as the polymerase processes a DNA template. For example, conformational changes in an enzyme may be accentuated by extending various domains in the enzyme. A polymerase enzyme may also be engineered to have additional charge groups that variably influence the internal conduction path as the enzyme processes a DNA template.
- In various embodiments, a circuit is exposed to a solution comprising modified dNTPs that variably influence the internal conduction path as the enzyme processes a DNA or RNA template. In some cases, the polymerase enzyme is a genetically modified form of one of: E. coli. Pol I polymerase, Bst polymerase, Taq polymerase, Phi29 polymerase, T7 polymerase, and reverse transcriptase. In other examples, a circuit is exposed to one or more of the conditions of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode.
- In various embodiments, the polymerase enzyme comprises a reverse transcriptase or genetically modified reverse transcriptase, capable of directly acting on an RNA template. Use of a reverse transcriptase in these circuits has the benefit that the reverse transcriptase can directly process an RNA template, and therefore provide a means for directly sequencing RNA molecules. In various aspects, this reverse transcriptase could be any monomeric reverse transcriptase or a genetically modified form thereof, such as Moloney murine leukemia virus reverse transcriptase, porcine endogenous retrovirus reverse transcriptase, bovine leukemia virus reverse transcriptase, mouse mammary tumor virus reverse transcriptase, or a heterodimeric reverse transcriptase such as human immunodeficiency virus reverse transcriptase or Rous sarcoma virus reverse transcriptase.
- In certain examples, a method of sequencing a DNA molecule is disclosed. The method comprises: providing an enzyme-based molecular circuit having spaced-apart positive and negative electrodes and a polymerase enzyme molecule connected to both the positive and negative electrodes to form a conductive pathway between the electrodes; initiating at least one of a voltage or a current through the circuit; exposing the circuit to a solution containing primed single stranded DNA and/or dNTPs; and measuring electrical signals through the circuit as the polymerase engages and extends a template, wherein the electrical signals are processed to identify features that provide information on the underlying sequence of the DNA molecule processed by the polymerase.
- In other aspects, a method of molecular detection is disclosed. The method comprises: (a) providing an enzyme-based molecular circuit having spaced-apart positive and negative electrodes, a polymerase enzyme molecule connected to both the positive and negative electrodes to form a conductive pathway between the electrodes, and a gate electrode; (b) initiating at least one of a voltage or a current through the circuit; (c) exposing the circuit to at least one of: a buffer of reduced ionic strength, a buffer comprising modified dNTPs, a buffer comprising altered divalent cation concentrations, specific applied voltage on the primary electrodes, a gate electrode voltage, or voltage spectroscopy or sweeping applied to the primary electrodes or gate electrode; and (d) measuring an electrical change in the circuit.
- Enzyme-based molecular sensors and methods of making and using same are provided. References to “various embodiments”, “one embodiment”, “an embodiment”, “an example embodiment”, etc., indicate that the embodiment described may include a particular feature, structure, or characteristic, but every embodiment may not necessarily include the particular feature, structure, or characteristic. Moreover, such phrases are not necessarily referring to the same embodiment. Further, when a particular feature, structure, or characteristic is described in connection with an embodiment, it is submitted that it is within the knowledge of one skilled in the art to affect such feature, structure, or characteristic in connection with other embodiments whether or not explicitly described. After reading the description, it will be apparent to one skilled in the relevant art(s) how to implement the disclosure in alternative embodiments.
- Benefits, other advantages, and solutions to problems have been described with regard to specific embodiments. However, the benefits, advantages, solutions to problems, and any elements that may cause any benefit, advantage, or solution to occur or become more pronounced are not to be construed as critical, required, or essential features or elements of the disclosure. The scope of the disclosure is accordingly to be limited by nothing other than the appended claims, in which reference to an element in the singular is not intended to mean “one and only one” unless explicitly so stated, but rather “one or more.” Moreover, where a phrase similar to ‘at least one of A, B, and C’ or ‘at least one of A, B, or C’ is used in the claims or specification, it is intended that the phrase be interpreted to mean that A alone may be present in an embodiment, B alone may be present in an embodiment, C alone may be present in an embodiment, or that any combination of the elements A, B and C may be present in a single embodiment; for example, A and B, A and C, B and C, or A and B and C.
- All structural, chemical, and functional equivalents to the elements of the above-described various embodiments that are known to those of ordinary skill in the art are expressly incorporated herein by reference and are intended to be encompassed by the present claims. Moreover, it is not necessary for a device or method to address each and every problem sought to be solved by the present disclosure, for it to be encompassed by the present claims. Furthermore, no element, component, or method step in the present disclosure is intended to be dedicated to the public regardless of whether the element, component, or method step is explicitly recited in the claims. No claim element is intended to invoke 35 U.S.C. 112(f) unless the element is expressly recited using the phrase “means for.” As used herein, the terms “comprises”, “comprising”, or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a molecule, composition, process, method, or device that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such molecules, compositions, processes, methods, or devices.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/586,772 US20220154241A1 (en) | 2017-04-25 | 2022-01-27 | Enzymatic circuits for molecular sensors |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762489881P | 2017-04-25 | 2017-04-25 | |
PCT/US2018/029382 WO2018200687A1 (en) | 2017-04-25 | 2018-04-25 | Enzymatic circuits for molecular sensors |
US16/015,028 US10508296B2 (en) | 2017-04-25 | 2018-06-21 | Enzymatic circuits for molecular sensors |
US16/684,338 US11268123B2 (en) | 2017-04-25 | 2019-11-14 | Enzymatic circuits for molecular sensors |
US17/586,772 US20220154241A1 (en) | 2017-04-25 | 2022-01-27 | Enzymatic circuits for molecular sensors |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/684,338 Continuation US11268123B2 (en) | 2017-04-25 | 2019-11-14 | Enzymatic circuits for molecular sensors |
Publications (1)
Publication Number | Publication Date |
---|---|
US20220154241A1 true US20220154241A1 (en) | 2022-05-19 |
Family
ID=63920073
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/684,338 Active US11268123B2 (en) | 2017-04-25 | 2019-11-14 | Enzymatic circuits for molecular sensors |
US17/138,314 Pending US20220002777A1 (en) | 2017-04-25 | 2020-12-30 | Enzymatic circuits for molecular sensors |
US17/586,772 Pending US20220154241A1 (en) | 2017-04-25 | 2022-01-27 | Enzymatic circuits for molecular sensors |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/684,338 Active US11268123B2 (en) | 2017-04-25 | 2019-11-14 | Enzymatic circuits for molecular sensors |
US17/138,314 Pending US20220002777A1 (en) | 2017-04-25 | 2020-12-30 | Enzymatic circuits for molecular sensors |
Country Status (6)
Country | Link |
---|---|
US (3) | US11268123B2 (en) |
EP (1) | EP3615685A4 (en) |
KR (2) | KR102692957B1 (en) |
CN (1) | CN110546276A (en) |
CA (1) | CA3057151A1 (en) |
WO (1) | WO2018200687A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11621345B2 (en) * | 2018-08-14 | 2023-04-04 | Pawan Tyagi | Systems and methods of fabricating gate electrode on trenched bottom electrode based molecular spintronics device |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3408219B1 (en) | 2016-01-28 | 2022-08-17 | Roswell Biotechnologies, Inc | Massively parallel dna sequencing apparatus |
KR20180105699A (en) | 2016-01-28 | 2018-09-28 | 로스웰 바이오테크놀로지스 인코포레이티드 | Methods and apparatus for measuring analytes using large scale molecular electronic device sensor arrays |
EP3882616A1 (en) | 2016-02-09 | 2021-09-22 | Roswell Biotechnologies, Inc | Electronic label-free dna and genome sequencing |
US10597767B2 (en) | 2016-02-22 | 2020-03-24 | Roswell Biotechnologies, Inc. | Nanoparticle fabrication |
US9829456B1 (en) | 2016-07-26 | 2017-11-28 | Roswell Biotechnologies, Inc. | Method of making a multi-electrode structure usable in molecular sensing devices |
WO2018132457A1 (en) | 2017-01-10 | 2018-07-19 | Roswell Biotechnologies, Inc. | Methods and systems for dna data storage |
KR102601324B1 (en) | 2017-01-19 | 2023-11-10 | 로스웰 바이오테크놀로지스 인코포레이티드 | Solid-state sequencing devices containing two-dimensional layer materials |
US10508296B2 (en) | 2017-04-25 | 2019-12-17 | Roswell Biotechnologies, Inc. | Enzymatic circuits for molecular sensors |
WO2018200687A1 (en) | 2017-04-25 | 2018-11-01 | Roswell Biotechnologies, Inc. | Enzymatic circuits for molecular sensors |
EP3622086A4 (en) | 2017-05-09 | 2021-04-21 | Roswell Biotechnologies, Inc | Binding probe circuits for molecular sensors |
WO2019046589A1 (en) | 2017-08-30 | 2019-03-07 | Roswell Biotechnologies, Inc. | Processive enzyme molecular electronic sensors for dna data storage |
WO2019075100A1 (en) | 2017-10-10 | 2019-04-18 | Roswell Biotechnologies, Inc. | Methods, apparatus and systems for amplification-free dna data storage |
WO2019217600A1 (en) | 2018-05-09 | 2019-11-14 | Stuart Lindsay | Method for electronic detection and quantification of antibodies |
CN114555832A (en) * | 2019-05-27 | 2022-05-27 | 通用测序技术公司 | Method for identifying components in nucleic acid sequences |
SG11202112851RA (en) | 2019-06-20 | 2021-12-30 | Univ Arizona State | Direct electrical readout of nucleic acid sequences |
LU101273B1 (en) * | 2019-06-21 | 2020-12-28 | Ecole Polytechnique Fed Lausanne Epfl | Sensing platform |
KR20220147602A (en) | 2020-02-28 | 2022-11-03 | 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 | How to sequence biopolymers |
US20240218415A1 (en) * | 2020-03-25 | 2024-07-04 | Universal Sequencing Technology Corporation | Enzyme mutants directly attached to a nanogap device |
EP4158063A4 (en) * | 2020-05-29 | 2024-05-29 | Arizona Board of Regents on behalf of Arizona State University | Bioelectronic devices with programmable adaptors |
WO2022140573A1 (en) * | 2020-12-22 | 2022-06-30 | Recognition AnalytiX, Inc. | Devices, methods, and systems for manipulating proteins in bioelectronic circuits |
Family Cites Families (286)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0233981Y2 (en) | 1986-05-13 | 1990-09-12 | ||
US4923586A (en) | 1987-03-31 | 1990-05-08 | Daikin Industries, Ltd. | Enzyme electrode unit |
US5082627A (en) | 1987-05-01 | 1992-01-21 | Biotronic Systems Corporation | Three dimensional binding site array for interfering with an electrical field |
US5486449A (en) | 1989-02-07 | 1996-01-23 | Rohm Co., Ltd. | Photomask, photoresist and photolithography for a monolithic IC |
GB2244135B (en) | 1990-05-04 | 1994-07-13 | Gen Electric Co Plc | Sensor devices |
US6051380A (en) | 1993-11-01 | 2000-04-18 | Nanogen, Inc. | Methods and procedures for molecular biological analysis and diagnostics |
IL103674A0 (en) | 1991-11-19 | 1993-04-04 | Houston Advanced Res Center | Method and apparatus for molecule detection |
US5414588A (en) | 1993-09-20 | 1995-05-09 | The Regents Of The University Of California | High performance capacitors using nano-structure multilayer materials fabrication |
US5366140A (en) | 1993-09-30 | 1994-11-22 | Minnesota Mining And Manufacturing Company | Patterned array of uniform metal microbeads |
US5965452A (en) | 1996-07-09 | 1999-10-12 | Nanogen, Inc. | Multiplexed active biologic array |
US5871918A (en) | 1996-06-20 | 1999-02-16 | The University Of North Carolina At Chapel Hill | Electrochemical detection of nucleic acid hybridization |
JP3149718B2 (en) | 1995-02-03 | 2001-03-26 | 松下電器産業株式会社 | Single electron transistor |
US5583359A (en) | 1995-03-03 | 1996-12-10 | Northern Telecom Limited | Capacitor structure for an integrated circuit |
US6673533B1 (en) | 1995-03-10 | 2004-01-06 | Meso Scale Technologies, Llc. | Multi-array multi-specific electrochemiluminescence testing |
US5639507A (en) | 1995-05-03 | 1997-06-17 | Avx Corporation | Method of making a planar multi-layer capacitor |
ES2223067T3 (en) | 1995-12-01 | 2005-02-16 | Innogenetics N.V. | IMPEDIMETRIC DETECTION SYSTEM AND PRODUCTION METHOD OF THE SAME. |
US6033582A (en) | 1996-01-22 | 2000-03-07 | Etex Corporation | Surface modification of medical implants |
US5881184A (en) | 1996-05-22 | 1999-03-09 | Eastman Kodak Company | Active pixel sensor with single pixel reset |
US6506564B1 (en) | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
US6202471B1 (en) | 1997-10-10 | 2001-03-20 | Nanomaterials Research Corporation | Low-cost multilaminate sensors |
US6110354A (en) | 1996-11-01 | 2000-08-29 | University Of Washington | Microband electrode arrays |
US5767687A (en) | 1996-11-29 | 1998-06-16 | Geist; Jon | Surface-capacitor type condensable-vapor sensor |
US6706473B1 (en) | 1996-12-06 | 2004-03-16 | Nanogen, Inc. | Systems and devices for photoelectrophoretic transport and hybridization of oligonucleotides |
US7169272B2 (en) | 1997-04-30 | 2007-01-30 | Board Of Trustees Of The University Of Arkansas | Microfabricated recessed disk microelectrodes: characterization in static and convective solutions |
US5982018A (en) | 1997-05-23 | 1999-11-09 | Micron Technology, Inc. | Thin film capacitor coupons for memory modules and multi-chip modules |
FR2764386B1 (en) | 1997-06-06 | 1999-07-16 | Commissariat Energie Atomique | ELECTRODES HOLDER COMPRISING AT LEAST ONE ELECTRODE COVERED BY A DEPOSIT AND READING SYSTEM THEREOF |
JP2000033712A (en) | 1997-09-30 | 2000-02-02 | Seiko Epson Corp | Method for forming micro-sensor device and method for evaluating liquid function using the same |
US6123819A (en) | 1997-11-12 | 2000-09-26 | Protiveris, Inc. | Nanoelectrode arrays |
US6537747B1 (en) | 1998-02-03 | 2003-03-25 | Lucent Technologies Inc. | Data transmission using DNA oligomers |
US6060023A (en) | 1998-03-31 | 2000-05-09 | Motorola, Inc. | Molecular sensing apparatus |
IL124322A (en) | 1998-05-04 | 2002-05-23 | Technion Res & Dev Foundation | Detection of an entity in a sample |
EP1086214B1 (en) | 1998-06-10 | 2009-11-25 | Georgia Tech Research Corporation | Microneedle devices and methods of their manufacture |
IL124903A0 (en) * | 1998-06-15 | 1999-01-26 | Bauer Alan Josef | An enzyme biosensor |
AU6412799A (en) | 1998-10-05 | 2000-04-26 | Mosaic Technologies | Reverse displacement assay for detection of nucleic acid sequences |
US6094335A (en) | 1998-10-09 | 2000-07-25 | Advanced Micro Devices, Inc. | Vertical parallel plate capacitor |
AU2640099A (en) | 1999-02-25 | 2000-09-14 | Seiko Epson Corporation | Structure member excellent in water-repellency and manufacturing method thereof |
US6517669B2 (en) | 1999-02-26 | 2003-02-11 | Micron Technology, Inc. | Apparatus and method of detecting endpoint of a dielectric etch |
EP1196629A2 (en) | 1999-04-07 | 2002-04-17 | Dennis Michael Connolly | High resolution dna detection methods and devices |
DE19916921A1 (en) | 1999-04-14 | 2000-10-19 | Fraunhofer Ges Forschung | Electrical sensor array |
US7122152B2 (en) | 1999-05-10 | 2006-10-17 | University Of Florida | Spatiotemporal and geometric optimization of sensor arrays for detecting analytes fluids |
AU7952700A (en) | 1999-10-20 | 2001-04-30 | Takatoshi Miyahara | Gene detecting chip, detector, and detecting method |
DE19960076C2 (en) | 1999-12-13 | 2002-12-05 | November Ag Molekulare Medizin | Method and device for the detection and quantification of biomolecules |
US20020090649A1 (en) | 1999-12-15 | 2002-07-11 | Tony Chan | High density column and row addressable electrode arrays |
DE10015818A1 (en) | 2000-03-30 | 2001-10-18 | Infineon Technologies Ag | Biosensor and method for determining macromolecular biopolymers using a biosensor |
AU2001252973A1 (en) | 2000-04-17 | 2001-10-30 | Purdue Research Foundation | Biosensor and related method |
AU6114501A (en) | 2000-05-03 | 2001-11-12 | Jen Gau Jr | Biological identification system with integrated sensor chip |
FR2811316B1 (en) | 2000-07-06 | 2003-01-10 | Saint Gobain | TRANSPARENT TEXTURE SUBSTRATE AND METHODS OF OBTAINING SAME |
US6670131B2 (en) | 2000-11-30 | 2003-12-30 | Kabushiki Kaisha Toshiba | Nucleic acid detection method and apparatus, and vessel for detecting nucleic acid |
NL1016779C2 (en) | 2000-12-02 | 2002-06-04 | Cornelis Johannes Maria V Rijn | Mold, method for manufacturing precision products with the aid of a mold, as well as precision products, in particular microsieves and membrane filters, manufactured with such a mold. |
DE10063739B4 (en) | 2000-12-21 | 2009-04-02 | Ferro Gmbh | Substrates with self-cleaning surface, process for their preparation and their use |
WO2002079514A1 (en) | 2001-01-10 | 2002-10-10 | The Trustees Of Boston College | Dna-bridged carbon nanotube arrays |
US6749731B2 (en) | 2001-01-31 | 2004-06-15 | Kyocera Corporation | Gene detection chip and detection device |
KR100878281B1 (en) | 2001-03-14 | 2009-01-12 | 유니버시티 오브 매사츄세츠 | Nanofabrication |
DE10113550A1 (en) | 2001-03-20 | 2002-10-02 | Infineon Technologies Ag | Method for detecting macromolecular biopolymers using an electrode arrangement |
US20040048241A1 (en) | 2001-06-11 | 2004-03-11 | Freeman Beverly Annette | Methods for attaching molecules |
US20040023253A1 (en) | 2001-06-11 | 2004-02-05 | Sandeep Kunwar | Device structure for closely spaced electrodes |
WO2003042396A2 (en) | 2001-06-11 | 2003-05-22 | Genorx, Inc. | Electronic detection of biological molecules using thin layers |
US6824974B2 (en) | 2001-06-11 | 2004-11-30 | Genorx, Inc. | Electronic detection of biological molecules using thin layers |
US7297494B2 (en) | 2001-06-25 | 2007-11-20 | Georgia Tech Research Corporation | Activatable probes and methods for in vivo gene detection |
WO2003006103A2 (en) | 2001-07-12 | 2003-01-23 | Merck & Co., Inc. | Electrical field stimulation of eukaryotic cells |
US6483125B1 (en) | 2001-07-13 | 2002-11-19 | North Carolina State University | Single electron transistors in which the thickness of an insulating layer defines spacing between electrodes |
US20030040000A1 (en) | 2001-08-08 | 2003-02-27 | Connolly Dennis M. | Methods for attaching nucleic acid molecules to electrically conductive surfaces |
WO2003020946A2 (en) | 2001-08-14 | 2003-03-13 | The Penn State Research Foundation | Fabrication of molecular scale devices using fluidic assembly |
US6861224B2 (en) | 2001-11-02 | 2005-03-01 | Fujitsu Limited | Protein detecting device |
US20030109031A1 (en) | 2001-11-06 | 2003-06-12 | Chafin David R. | System for detecting biological materials in a sample |
US6905586B2 (en) | 2002-01-28 | 2005-06-14 | Ut-Battelle, Llc | DNA and RNA sequencing by nanoscale reading through programmable electrophoresis and nanoelectrode-gated tunneling and dielectric detection |
US6743368B2 (en) | 2002-01-31 | 2004-06-01 | Hewlett-Packard Development Company, L.P. | Nano-size imprinting stamp using spacer technique |
AU2003243165A1 (en) | 2002-04-26 | 2003-11-10 | The Penn State Research Foundation | Integrated nanomechanical sensor array chips |
US20040014106A1 (en) | 2002-05-14 | 2004-01-22 | Nanosphere, Inc. | Electrical detection of DNA hybridization and specific binding events |
US20030224387A1 (en) | 2002-05-22 | 2003-12-04 | Sandeep Kunwar | Association of molecules with electrodes of an array of electrodes |
EP1516377A2 (en) | 2002-06-05 | 2005-03-23 | Reveo, Inc. | Layered electrochemical cell and manufacturing method therefor |
EP1376111A1 (en) | 2002-06-24 | 2004-01-02 | Universite Catholique De Louvain | Method and device for high sensitivity detection of the presence of DNA and other probes |
JP4196947B2 (en) | 2002-07-02 | 2008-12-17 | パナソニック株式会社 | Biosensor, biosensor chip and biosensor device |
US6755423B2 (en) | 2002-07-17 | 2004-06-29 | Li Jiun Chiu | Tool coupling device for changeable tool members |
US7470533B2 (en) | 2002-12-20 | 2008-12-30 | Acea Biosciences | Impedance based devices and methods for use in assays |
DE10242560A1 (en) | 2002-09-13 | 2004-03-25 | Creavis Gesellschaft Für Technologie Und Innovation Mbh | Process for preparation of self-cleaning surfaces on coated flat textile structures useful for cladding technical textiles and structures obtained from these and production of raincoats and safety clothing with signaling effect |
US20040063100A1 (en) | 2002-09-30 | 2004-04-01 | Wang Chung Lin | Nanoneedle chips and the production thereof |
DE10247679A1 (en) | 2002-10-12 | 2004-04-22 | Fujitsu Ltd., Kawasaki | Semiconductor body structure, as a biosensor, has two thick layers of one material separated by a thin different intermediate layer forming a nano gap, with organic wire structures as the contacts |
US7183055B2 (en) | 2002-11-01 | 2007-02-27 | Wisconsin Alumni Research Foundation | Direct radio-frequency detection of nucleotide hybridization at microelectrodes |
WO2004065570A2 (en) | 2003-01-23 | 2004-08-05 | Integrated Nano-Technologies, Llc | Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces |
CA2516820A1 (en) | 2003-02-07 | 2004-11-18 | Wisconsin Alumni Research Foundation | Nanocylinder-modified surfaces |
US20050164371A1 (en) | 2003-03-28 | 2005-07-28 | Fujitsu Limited | Cavity electrode structure, and sensor and protein detection device using the same |
US7172917B2 (en) | 2003-04-17 | 2007-02-06 | Robert Bosch Gmbh | Method of making a nanogap for variable capacitive elements, and device having a nanogap |
JP4871726B2 (en) | 2003-04-28 | 2012-02-08 | ナノシス・インク. | Super lyophobic surface, its preparation and use |
WO2004096986A2 (en) | 2003-04-29 | 2004-11-11 | Integrated Nano-Technologies, Llc | Method for quantitative detection of nucleic acid molecules |
JP2004347532A (en) | 2003-05-23 | 2004-12-09 | Japan Science & Technology Agency | Biosensor |
US20050156157A1 (en) | 2003-07-21 | 2005-07-21 | Parsons Gregory N. | Hierarchical assembly of interconnects for molecular electronics |
JP4059181B2 (en) | 2003-09-29 | 2008-03-12 | 株式会社村田製作所 | Manufacturing method of multi-terminal type multilayer ceramic electronic components |
JP2005109269A (en) | 2003-09-30 | 2005-04-21 | Hitachi Ltd | Semiconductor radiation detector and semiconductor radiation imager |
US7132298B2 (en) | 2003-10-07 | 2006-11-07 | Hewlett-Packard Development Company, L.P. | Fabrication of nano-object array |
WO2005081707A2 (en) | 2003-11-20 | 2005-09-09 | Biowarn, Llc | Methodology and apparatus for the detection of biological substances |
WO2005108612A2 (en) | 2003-11-28 | 2005-11-17 | Genorx, Inc. | Nanoscale biosensor device, system and technique |
ATE458194T1 (en) | 2003-12-16 | 2010-03-15 | Dynabyte Informationssysteme G | CONNECTOR MODULE FOR BLOOD ANALYSIS |
DE10359173B4 (en) | 2003-12-17 | 2006-11-09 | Robert Bosch Gmbh | Measuring device with a plurality of potentiometric electrode pairs arranged on a substrate |
US7451381B2 (en) | 2004-02-03 | 2008-11-11 | Phonex Broadband Corporation | Reliable method and system for efficiently transporting dynamic data across a network |
US20050247573A1 (en) | 2004-03-23 | 2005-11-10 | Hideaki Nakamura | Biosensors |
US8354066B2 (en) | 2004-03-24 | 2013-01-15 | Technion Research & Development Foundation Ltd. | Artificial receptors |
US20050221473A1 (en) | 2004-03-30 | 2005-10-06 | Intel Corporation | Sensor array integrated circuits |
US8138496B2 (en) | 2004-04-01 | 2012-03-20 | Nanyang Technological University | Addressable transistor chip for conducting assays |
US20060019273A1 (en) | 2004-05-12 | 2006-01-26 | Connolly Dennis M | Detection card for analyzing a sample for a target nucleic acid molecule, and uses thereof |
US7385295B2 (en) | 2004-06-24 | 2008-06-10 | California Institute Of Technology | Fabrication of nano-gap electrode arrays by the construction and selective chemical etching of nano-crosswire stacks |
US7265019B2 (en) | 2004-06-30 | 2007-09-04 | International Business Machines Corporation | Elastomeric CMOS based micro electromechanical varactor |
US7150904B2 (en) | 2004-07-27 | 2006-12-19 | Ut-Battelle, Llc | Composite, ordered material having sharp surface features |
US7258731B2 (en) | 2004-07-27 | 2007-08-21 | Ut Battelle, Llc | Composite, nanostructured, super-hydrophobic material |
US7655275B2 (en) | 2004-08-02 | 2010-02-02 | Hewlett-Packard Delopment Company, L.P. | Methods of controlling flow |
US20060029808A1 (en) | 2004-08-06 | 2006-02-09 | Lei Zhai | Superhydrophobic coatings |
EP1630882B1 (en) | 2004-08-31 | 2012-05-02 | STMicroelectronics S.r.l. | Nanometric structure and corresponding manufacturing method |
DE602004016496D1 (en) | 2004-08-31 | 2008-10-23 | St Microelectronics Srl | Process for the preparation of a host structure for nanometer-sized elements |
DE102004042729B4 (en) | 2004-09-03 | 2018-02-01 | Robert Bosch Gmbh | Bio-chip with an electrode array on a substrate |
US20070048748A1 (en) | 2004-09-24 | 2007-03-01 | Li-Cor, Inc. | Mutant polymerases for sequencing and genotyping |
US7507320B2 (en) | 2004-10-09 | 2009-03-24 | Academia Sinica | Single-atom tip and preparation method thereof |
EP1810015A1 (en) | 2004-10-14 | 2007-07-25 | Kabushiki Kaisha Toshiba | Fet-based nucleic acid detecting sensor |
US7541004B2 (en) | 2004-11-12 | 2009-06-02 | Predict, Inc. | MEMS-based sensor for lubricant analysis |
US7785785B2 (en) | 2004-11-12 | 2010-08-31 | The Board Of Trustees Of The Leland Stanford Junior University | Charge perturbation detection system for DNA and other molecules |
DE102004060738B4 (en) | 2004-12-15 | 2008-07-03 | Forschungszentrum Jülich GmbH | Process for the structured application of molecules to a conductor track |
EP1848990A1 (en) | 2005-02-18 | 2007-10-31 | Midorion Ab | Sensor for detection of single molecules |
US9695472B2 (en) | 2005-03-04 | 2017-07-04 | Intel Corporation | Sensor arrays and nucleic acid sequencing applications |
WO2006102292A2 (en) | 2005-03-21 | 2006-09-28 | The Trustees Of The University Of Pennsylvania | Nanogaps: methods and devices containing same |
US20090062684A1 (en) | 2005-03-31 | 2009-03-05 | Globalreach Holding Aps | Apparatus and method for a global model of hollow internal organs including the determination of cross-sectional areas and volume in internal hollow organs and wall properties |
WO2006132694A2 (en) | 2005-04-01 | 2006-12-14 | Clemson University | Ultrahydrophobic substrates |
US7579184B2 (en) | 2005-06-02 | 2009-08-25 | Board Of Trustees Of Michigan State University | Methods to increase dynamic range and improve quantitative analysis in rapid biosensors |
US7417418B1 (en) | 2005-06-14 | 2008-08-26 | Ayliffe Harold E | Thin film sensor |
WO2007053242A2 (en) | 2005-09-19 | 2007-05-10 | Wayne State University | Transparent hydrophobic article having self-cleaning and liquid repellant features and method of fabricating same |
FR2893266B1 (en) | 2005-11-14 | 2007-12-21 | Commissariat Energie Atomique | SUPERHYDROPHIL OR SUPERHYDROPHOBIC PRODUCT, PROCESS FOR PRODUCING THE SAME AND USE THEREOF |
KR100757389B1 (en) | 2005-12-06 | 2007-09-11 | 한국전자통신연구원 | Sensors having nano-gap electrode and their manufacturing method |
EP1977444A4 (en) | 2005-12-15 | 2009-05-13 | Univ Columbia | Sensing devices from molecular electronic devices |
US8706219B2 (en) | 2005-12-22 | 2014-04-22 | Board Of Regents, The University Of Texas System | Method and apparatus for monitoring an organ of a patient |
US7649198B2 (en) | 2005-12-28 | 2010-01-19 | Industrial Technology Research Institute | Nano-array and fabrication method thereof |
WO2007087377A2 (en) | 2006-01-25 | 2007-08-02 | Massachusetts Institute Of Technology | Photoelectrochemical synthesis of high density combinatorial polymer arrays |
WO2007102960A2 (en) | 2006-01-30 | 2007-09-13 | Ashland Licensing And Intellectual Property Llc | Hydrophobic self-cleaning coating compositions |
US20070184247A1 (en) | 2006-02-03 | 2007-08-09 | Simpson John T | Transparent, super-hydrophobic, disordered composite material |
US7357018B2 (en) | 2006-02-10 | 2008-04-15 | Agilent Technologies, Inc. | Method for performing a measurement inside a specimen using an insertable nanoscale FET probe |
EP2002248A1 (en) | 2006-03-17 | 2008-12-17 | Element Six Limited | Microelectrode array |
US20090011222A1 (en) | 2006-03-27 | 2009-01-08 | Georgia Tech Research Corporation | Superhydrophobic surface and method for forming same |
US20070227300A1 (en) | 2006-03-31 | 2007-10-04 | Quantumsphere, Inc. | Compositions of nanometal particles containing a metal or alloy and platinum particles for use in fuel cells |
US20070231542A1 (en) | 2006-04-03 | 2007-10-04 | General Electric Company | Articles having low wettability and high light transmission |
GB2437328A (en) | 2006-04-10 | 2007-10-24 | Cambridge Display Tech Ltd | Electric devices and methods of manufacture |
GB0607205D0 (en) | 2006-04-10 | 2006-05-17 | Diagnoswiss Sa | Miniaturised biosensor with optimized anperimetric detection |
US20090162927A1 (en) | 2006-05-31 | 2009-06-25 | Yeda Research And Development Company Ltd. | Nanotubes and nanowires based electronic devices and method of fabrication thereof |
JP2008026109A (en) | 2006-07-20 | 2008-02-07 | Fujifilm Corp | Fine structure, its manufacturing method, sensor device and raman spectroscopic device |
US8394590B2 (en) | 2006-08-02 | 2013-03-12 | California Institute Of Technology | Capture agents and related methods and systems for detecting and/or sorting targets |
WO2008020813A1 (en) | 2006-08-16 | 2008-02-21 | Agency For Science, Technology And Research | Method of electrically detecting a biological analyte molecule |
ITTO20060774A1 (en) | 2006-10-27 | 2008-04-28 | St Microelectronics Srl | MICROELETTROMECHANICAL SENSOR WITH MULTIPLE SCALES VALUES AND SENSITIVITY |
JP4986138B2 (en) | 2006-11-15 | 2012-07-25 | 独立行政法人産業技術総合研究所 | Method for manufacturing mold for optical element having antireflection structure |
EP2653861B1 (en) | 2006-12-14 | 2014-08-13 | Life Technologies Corporation | Method for sequencing a nucleic acid using large-scale FET arrays |
GB0625070D0 (en) | 2006-12-15 | 2007-01-24 | Imp Innovations Ltd | Characterization of molecules |
JP2008258594A (en) | 2007-03-09 | 2008-10-23 | Hokkaido Univ | Method of manufacturing carbon nanotube field-effect transistor, and biosensor device |
KR100854486B1 (en) | 2007-04-05 | 2008-08-26 | 한국기계연구원 | Manufacturing method for super water-repellent surface |
US9139614B2 (en) | 2007-04-25 | 2015-09-22 | The United States Of America, As Represented By The Secretary Of The Navy | Modular linkers for conjugation of organic substances to substantially inorganic substances and methods of manufacture and use thereof |
AT505495A1 (en) | 2007-07-04 | 2009-01-15 | Arc Austrian Res Centers Gmbh | METHOD FOR IDENTIFYING AND QUANTIFYING ORGANIC AND BIOCHEMICAL SUBSTANCES |
US8278188B2 (en) | 2007-07-19 | 2012-10-02 | University of Pittsburgh—of the Commonwealth System of Higher Education | Manipulation, detection, and assay of small scale biological particles |
EP2195648B1 (en) | 2007-09-12 | 2019-05-08 | President and Fellows of Harvard College | High-resolution molecular graphene sensor comprising an aperture in the graphene layer |
US20100285601A1 (en) | 2007-09-28 | 2010-11-11 | Agency For Science, Technology And Research | Method of electrically detecting a nucleic acid molecule |
WO2009070796A1 (en) | 2007-11-29 | 2009-06-04 | President And Fellows Of Harvard College | Assembly and deposition of materials using a superhydrophobic surface structure |
WO2009082706A1 (en) | 2007-12-21 | 2009-07-02 | The Trustees Of Columbia University In The City Of New York | Active cmos sensor array for electrochemical biomolecular detection |
US8372585B2 (en) | 2007-12-31 | 2013-02-12 | Intel Corporation | Electronic sensing for nucleic acid sequencing |
US8304273B2 (en) | 2008-01-24 | 2012-11-06 | Massachusetts Institute Of Technology | Insulated nanogap devices and methods of use thereof |
US8183648B2 (en) | 2008-01-25 | 2012-05-22 | Ut-Battelle, Llc | Nanoscopic electrode molecular probes |
CN101231287B (en) | 2008-02-22 | 2011-09-14 | 东南大学 | Method for preparing biosensor by arraying nanometer particles in external field evoked electrode |
US20090297913A1 (en) | 2008-03-25 | 2009-12-03 | The University Of Georgia Research Foundation, Inc. | Nanostructure-Enhanced stereo-electrodes for fuel cells and biosensors |
US8753893B2 (en) | 2008-06-19 | 2014-06-17 | Ben H. Liu | Multi-dimensional fluid sensors and related detectors and methods |
US7970332B2 (en) | 2008-06-30 | 2011-06-28 | Xerox Corporation | Oil less fusing using nano/micro textured fusing surfaces |
WO2010044932A2 (en) | 2008-07-11 | 2010-04-22 | Cornell University | Nanofluidic channels with integrated charge sensors and methods based thereon |
WO2010019887A1 (en) | 2008-08-14 | 2010-02-18 | Brookhaven Science Associates | Structured pillar electrodes |
WO2010022107A2 (en) | 2008-08-18 | 2010-02-25 | The Regents Of The University Of California | Nanostructured superhydrophobic, superoleophobic and/or superomniphobic coatings, methods for fabrication, and applications thereof |
US20100044212A1 (en) | 2008-08-21 | 2010-02-25 | Snu R&Db Foundation | Vertically standing ionic polymer-metal composite |
ES2636664T3 (en) | 2008-09-02 | 2017-10-06 | The Governing Council Of The University Of Toronto | Nanostructured microelectrodes and biodetection devices that incorporate them |
US20100132771A1 (en) | 2008-10-06 | 2010-06-03 | The Regents Of The University Of California | 3D Carbon Nanotubes Membrane as a Solar Energy Absorbing Layer |
EP2350644B1 (en) | 2008-11-18 | 2015-01-07 | THE UNITED STATES OF AMERICA as represented by the Secretary, Department of Health and Human Services | A semiconductor for measuring biological interactions |
US8563240B2 (en) | 2008-12-31 | 2013-10-22 | Intel Corporation | Nucleic acid sequencing and electronic detection |
US8283936B2 (en) | 2009-02-09 | 2012-10-09 | Board Of Regents, The University Of Texas System | Nano-scale biosensors |
US20100206367A1 (en) | 2009-02-18 | 2010-08-19 | Korea Institute Of Industrial Technology | Method for fabricating silicon nano wire, solar cell including silicon nano wire and method for fabricating solar cell |
US8106428B2 (en) | 2009-03-03 | 2012-01-31 | Board Of Regents, The University Of Texas System | Nano-scale bridge biosensors |
WO2010104479A1 (en) | 2009-03-11 | 2010-09-16 | Agency For Science, Technology And Research | Electrical sensor for ultrasensitive nucleic acid detection |
US20100288543A1 (en) | 2009-04-14 | 2010-11-18 | Nanoink, Inc. | Conducting lines, nanoparticles, inks, and patterning |
US20110291673A1 (en) | 2009-04-27 | 2011-12-01 | Sharp Kabushiki Kaisha | Chemical sensor |
US20100285272A1 (en) | 2009-05-06 | 2010-11-11 | Shari Elizabeth Koval | Multi-length scale textured glass substrates for anti-fingerprinting |
US8313633B2 (en) | 2009-07-28 | 2012-11-20 | Polestar Technologies, Inc. | Molecular imprinted nanosensors and process for producing same |
US8911972B2 (en) * | 2009-12-16 | 2014-12-16 | Pacific Biosciences Of California, Inc. | Sequencing methods using enzyme conformation |
EP2366994A1 (en) | 2010-03-18 | 2011-09-21 | Wolfgang Knoll | Biosensor on thin-film transistors |
US8940663B2 (en) | 2010-04-07 | 2015-01-27 | Board Of Regents, The University Of Texas System | Nano-scale biosensors |
US20110311853A1 (en) | 2010-06-17 | 2011-12-22 | Lsi Corporation | Electrochemical cell system and apparatus to provide energy to a portable electronic device |
WO2011159942A1 (en) | 2010-06-18 | 2011-12-22 | Illumina, Inc. | Conformational probes and methods for sequencing nucleic acids |
KR101136534B1 (en) | 2010-09-07 | 2012-04-17 | 한국기계연구원 | Probe card and manufacturing method thereof |
US9231133B2 (en) | 2010-09-10 | 2016-01-05 | International Business Machines Corporation | Nanowires formed by employing solder nanodots |
US9070492B2 (en) | 2010-09-14 | 2015-06-30 | The General Hospital Corporation | Nanoporous metal multiple electrode array and method of making same |
US9187783B2 (en) | 2010-10-04 | 2015-11-17 | Genapsys, Inc. | Systems and methods for automated reusable parallel biological reactions |
WO2012054904A2 (en) | 2010-10-21 | 2012-04-26 | The Regents Of The University Of California | Microfluidics with wirelessly powered electronic circuits |
GB2485559A (en) | 2010-11-18 | 2012-05-23 | Univ Plymouth | Graphene based electronic device |
US20120258881A1 (en) | 2010-11-22 | 2012-10-11 | The University Of Chicago | Methods and/or Use of Oligonucleotide Conjugates for Assays and Microscopy/Imaging Detections |
ES2641871T3 (en) | 2010-12-17 | 2017-11-14 | The Trustees Of Columbia University In The City Of New York | DNA sequencing by synthesis using modified nucleotides and nanopore detection |
US9956743B2 (en) | 2010-12-20 | 2018-05-01 | The Regents Of The University Of California | Superhydrophobic and superoleophobic nanosurfaces |
RU2564923C2 (en) | 2010-12-31 | 2015-10-10 | Цилаг Гмбх Интернэшнл | Systems and methods for high-accuracy analyte measurement |
US9608101B2 (en) | 2011-01-04 | 2017-03-28 | Ecole Polytechnique Federale De Lausanne (Epfl) | Semiconductor device |
TW201231948A (en) | 2011-01-26 | 2012-08-01 | zhi-yu Zhao | Method for forming frozen biological test strip for electron microscope and device thereof |
US8652768B1 (en) | 2011-01-31 | 2014-02-18 | Sandia Corporation | Nanopatterns by phase separation of patterned mixed polymer monolayers |
EP2492673A1 (en) | 2011-02-28 | 2012-08-29 | Lexogen GmbH | Biosensor array formed by junctions of functionalized electrodes |
EP2492674A1 (en) | 2011-02-28 | 2012-08-29 | Lexogen GmbH | Biosensor array formed by junctions of functionalized electrodes |
US20140054788A1 (en) | 2011-03-08 | 2014-02-27 | Japan Science And Technology Agency | Method for fabricating nanogap electrodes, nanogap electrodes array, and nanodevice with the same |
US20140045190A1 (en) | 2011-04-19 | 2014-02-13 | The Hong Kong University Of Science And Technology | Method and device for monitoring real-time polymerase chain reaction (pcr) utilizing electro-active hydrolysis probe (e-tag probe) |
WO2012146377A1 (en) | 2011-04-27 | 2012-11-01 | Dmitry Cherkasov | Method and components for detecting nucleic acid chains |
KR101548771B1 (en) | 2011-06-23 | 2015-09-01 | 삼성전기주식회사 | Chip type laminated capacitor |
KR102023754B1 (en) | 2011-07-27 | 2019-09-20 | 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 | Nanopore sensors for biomolecular characterization |
KR20140050046A (en) | 2011-08-04 | 2014-04-28 | 닛산 가가쿠 고교 가부시키 가이샤 | Resist underlayer film-forming composition for euv lithography containing condensation polymer |
US8685858B2 (en) | 2011-08-30 | 2014-04-01 | International Business Machines Corporation | Formation of metal nanospheres and microspheres |
WO2013095730A2 (en) | 2011-09-19 | 2013-06-27 | University Of Utah Research Foundation | Multimode platform for detection of compounds |
US9347900B2 (en) | 2011-10-14 | 2016-05-24 | Pacific Biosciences Of California, Inc. | Real-time redox sequencing |
US20130108956A1 (en) | 2011-11-01 | 2013-05-02 | Az Electronic Materials Usa Corp. | Nanocomposite positive photosensitive composition and use thereof |
EP2788480B1 (en) * | 2011-12-08 | 2019-01-16 | Roche Diagnostics GmbH | Dna polymerases with improved activity |
GB2511230B (en) | 2011-12-15 | 2018-03-14 | Intel Corp | Diamond electrode nanogap transducers |
EP4108782B1 (en) | 2011-12-22 | 2023-06-07 | President and Fellows of Harvard College | Compositions and methods for analyte detection |
US20130183492A1 (en) | 2012-01-17 | 2013-07-18 | Snu R&Db Foundation | Metal nanoparticles on substrate and method of forming the same |
US20130214875A1 (en) | 2012-02-16 | 2013-08-22 | Elwha Llc | Graphene sheet and nanomechanical resonator |
US20130239349A1 (en) | 2012-03-14 | 2013-09-19 | Palo Alto Research Center Incorporated | Self-powered manual toothbrush with sensors |
UA116205C2 (en) | 2012-04-09 | 2018-02-26 | Енвіролоджикс Інк. | Compositions and methods for quantifying a nucleic acid sequence in a sample |
US9393590B2 (en) | 2012-04-16 | 2016-07-19 | Temple University—Of the Commonwealth System of Higher Education | Self-assembly of small structures |
WO2013165588A1 (en) | 2012-05-01 | 2013-11-07 | Life Technologies Corporation | Methods for analysis of dna fragments |
CN102706940B (en) | 2012-06-15 | 2014-05-14 | 湖南大学 | Electrochemical sensor capable of detecting trace mercury in water body, and preparation method and application thereof |
US9551682B2 (en) | 2012-06-29 | 2017-01-24 | Intel Corporation | High throughput biochemical detection using single molecule fingerprinting arrays |
EP2875128B8 (en) | 2012-07-19 | 2020-06-24 | Oxford Nanopore Technologies Limited | Modified helicases |
US8741688B2 (en) | 2012-07-24 | 2014-06-03 | Micron Technology, Inc. | Methods of forming a metal chalcogenide material |
US9070733B2 (en) | 2012-07-25 | 2015-06-30 | California Institute Of Technology | Nanopillar field-effect and junction transistors with functionalized gate and base electrodes |
JP2015528282A (en) | 2012-08-06 | 2015-09-28 | クワンタムディーエックス・グループ・リミテッド | Methods and kits for nucleic acid sequencing |
TWI492384B (en) | 2012-08-17 | 2015-07-11 | Univ Nat Chiao Tung | Protein transistor devic |
TWI514566B (en) | 2012-09-19 | 2015-12-21 | Univ Nat Chiao Tung | Semiconductor bio-nanowire device and method for fabricating the same |
ES2750635T3 (en) | 2012-10-16 | 2020-03-26 | Abbott Lab | Method of increasing the length of Debye on the surface of a sensor in a sample solution and the corresponding computer-readable storage medium |
WO2014066770A1 (en) | 2012-10-26 | 2014-05-01 | Research Triangle Institute, International | Intermediate band semiconductors, heterojunctions, and optoelectronic devices utilizing solution processed quantum dots, and related methods |
US20150293025A1 (en) | 2012-12-18 | 2015-10-15 | Toray Industries Inc. | Metal dot substrate and method of manufacturing metal dot substrate |
US20140218637A1 (en) | 2013-02-06 | 2014-08-07 | Nanchang O-Film Tech. Co., Ltd. | Conductive film, manufacturing method thereof, and touch screen including the conducting film |
CN103187119B (en) | 2013-02-06 | 2014-08-06 | 南昌欧菲光科技有限公司 | Conductive film, preparation method for conductive film and touch screen comprising conductive film |
US9040363B2 (en) | 2013-03-20 | 2015-05-26 | International Business Machines Corporation | FinFET with reduced capacitance |
FR3003751A1 (en) | 2013-03-27 | 2014-10-03 | Jacques Geloen | SATURATION VISUALIZATION DEVICE FOR PROTECTION OF UROFECAL INCONTINENCE. |
US9915614B2 (en) | 2013-04-26 | 2018-03-13 | Academia Sinica | Microfluidic systems and devices for molecular capture, manipulation, and analysis |
EP2994544B1 (en) | 2013-05-06 | 2019-10-02 | Pacific Biosciences Of California, Inc. | Real-time electronic sequencing |
US8901621B1 (en) | 2013-06-18 | 2014-12-02 | International Business Machines Corporation | Nanochannel process and structure for bio-detection |
US9182369B2 (en) | 2013-06-19 | 2015-11-10 | Globalfoundries Inc. | Manufacturable sub-3 nanometer palladium gap devices for fixed electrode tunneling recognition |
TW201502276A (en) * | 2013-07-09 | 2015-01-16 | Univ Nat Chiao Tung | Sequencing method for label-free single molecular nucleic acid |
DE102013012145A1 (en) * | 2013-07-20 | 2015-01-22 | Borros Arneth | Protein transistor based on anti-silicon antibody |
US20150049332A1 (en) | 2013-07-30 | 2015-02-19 | The Curators Of The University Of Missouri | Gold nanoisland arrays |
CN106104274B (en) | 2013-09-18 | 2018-05-22 | 量子生物有限公司 | biomolecule sequencing device, system and method |
US9236841B2 (en) | 2013-09-19 | 2016-01-12 | Analog Devices, Inc. | Current-feedback operational amplifier |
WO2015102746A2 (en) | 2013-11-04 | 2015-07-09 | Massachusetts Institute Of Technology | Electronics including graphene-based hybrid structures |
CN105980580B (en) | 2013-11-17 | 2020-03-03 | 宽腾矽公司 | Optical system and assay chip for detecting, detecting and analyzing molecules |
US10746683B2 (en) | 2013-12-12 | 2020-08-18 | Altratech Limited | Capacitive sensor and method of use |
US9472396B2 (en) | 2014-04-15 | 2016-10-18 | University Of Central Florida Research Foundation, Inc. | Plasma treated semiconductor dichalcogenide materials and devices therefrom |
TW201602355A (en) | 2014-04-28 | 2016-01-16 | 量子生物系統公司 | Nanogap electrode devices and systems and methods for forming the same |
EP2947779A1 (en) | 2014-05-23 | 2015-11-25 | Thomson Licensing | Method and apparatus for storing information units in nucleic acid molecules and nucleic acid storage system |
SG11201609692SA (en) | 2014-06-03 | 2016-12-29 | Illumina Inc | Compositions, systems, and methods for detecting events using tethers anchored to or adjacent to nanopores |
AU2015269053A1 (en) | 2014-06-06 | 2016-12-22 | Solstice Biologics, Ltd. | Polynucleotide constructs having bioreversible and non-bioreversible groups |
DK3460075T3 (en) | 2014-07-15 | 2021-02-01 | Illumina Inc | Biochemically activated electronic device |
GB2528682A (en) | 2014-07-28 | 2016-02-03 | Isis Innovation | Plasmonic filter |
JP6443699B2 (en) | 2014-08-29 | 2018-12-26 | 国立研究開発法人科学技術振興機構 | Nanodevice |
US9859513B2 (en) | 2014-11-25 | 2018-01-02 | University Of Kentucky Research Foundation | Integrated multi-terminal devices consisting of carbon nanotube, few-layer graphene nanogaps and few-layer graphene nanoribbons having crystallographically controlled interfaces |
US9618474B2 (en) | 2014-12-18 | 2017-04-11 | Edico Genome, Inc. | Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids |
CA2971268A1 (en) * | 2014-12-18 | 2016-06-23 | The Regents Of The University Of California | Detection of nucleic acid polymerase conformational changes using a nanotube |
US20160187282A1 (en) | 2014-12-26 | 2016-06-30 | Intel Corporation | Device for single molecule detection and fabrication methods thereof |
US9306164B1 (en) | 2015-01-30 | 2016-04-05 | International Business Machines Corporation | Electrode pair fabrication using directed self assembly of diblock copolymers |
WO2016157117A1 (en) | 2015-03-31 | 2016-10-06 | Rg Smart Pte. Ltd. | Nanoelectronic sensor pixel |
FR3035220A1 (en) | 2015-04-20 | 2016-10-21 | Commissariat Energie Atomique | "ELECTRONIC DEVICE FOR MEASURING AT LEAST ONE ELECTRICAL CHARACTERISTIC OF AN OBJECT" |
RU2713396C2 (en) * | 2015-06-03 | 2020-02-05 | Иллюмина, Инк. | Compositions, systems and methods for sequencing polynucleotides using connective structures attached to polymerases located near nanopores |
JP7166586B2 (en) * | 2015-06-25 | 2022-11-08 | ロズウェル バイオテクノロジーズ,インコーポレイテッド | Biomolecular sensor and method |
EP3332033B1 (en) * | 2015-08-06 | 2021-04-21 | Pacific Biosciences of California, Inc. | Single-molecule nanofet sequencing systems and methods |
WO2017027518A1 (en) * | 2015-08-10 | 2017-02-16 | Stratos Genomics, Inc. | Single molecule nucleic acid sequencing with molecular sensor complexes |
WO2017041056A1 (en) | 2015-09-02 | 2017-03-09 | Agilome, Inc. | Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same |
CN108350017B (en) * | 2015-09-10 | 2022-03-15 | 豪夫迈·罗氏有限公司 | Polypeptide-labeled nucleotides and their use in nucleic acid sequencing by nanopore detection |
JP2018533935A (en) | 2015-10-08 | 2018-11-22 | クオンタムバイオシステムズ株式会社 | Nucleic acid sequencing apparatus, system and method |
WO2017123416A1 (en) | 2016-01-14 | 2017-07-20 | Roswell Biotechnologies, Inc. | Molecular sensors and related methods |
EP3408219B1 (en) | 2016-01-28 | 2022-08-17 | Roswell Biotechnologies, Inc | Massively parallel dna sequencing apparatus |
KR20180105699A (en) | 2016-01-28 | 2018-09-28 | 로스웰 바이오테크놀로지스 인코포레이티드 | Methods and apparatus for measuring analytes using large scale molecular electronic device sensor arrays |
EP3882616A1 (en) | 2016-02-09 | 2021-09-22 | Roswell Biotechnologies, Inc | Electronic label-free dna and genome sequencing |
US10597767B2 (en) | 2016-02-22 | 2020-03-24 | Roswell Biotechnologies, Inc. | Nanoparticle fabrication |
WO2017151680A2 (en) | 2016-02-29 | 2017-09-08 | Dodo Omnidata, Inc. | Methods, compositions, and devices for information storage |
US10883140B2 (en) | 2016-04-21 | 2021-01-05 | President And Fellows Of Harvard College | Method and system of nanopore-based information encoding |
JP2019524385A (en) | 2016-05-19 | 2019-09-05 | ドラゴン メディカル ディベロプメント リミテッドDragon Medical Development Limited | Guidewire device and method for multi-parameter analysis of coronary stenosis |
US20180014786A1 (en) | 2016-07-15 | 2018-01-18 | Dragon Medical Development Limited | Multi-spline, multi-electrode catheter and method of use for mapping of internal organs |
US9829456B1 (en) | 2016-07-26 | 2017-11-28 | Roswell Biotechnologies, Inc. | Method of making a multi-electrode structure usable in molecular sensing devices |
KR102526825B1 (en) | 2016-08-01 | 2023-04-27 | 로스웰 바이오테크놀로지스 인코포레이티드 | Modified Nucleotide Triphosphates for Molecular Electronic Sensors |
WO2018098286A1 (en) | 2016-11-22 | 2018-05-31 | Roswell Biotechnologies, Inc. | Nucleic acid sequencing device containing graphene |
WO2018132457A1 (en) | 2017-01-10 | 2018-07-19 | Roswell Biotechnologies, Inc. | Methods and systems for dna data storage |
KR102601324B1 (en) | 2017-01-19 | 2023-11-10 | 로스웰 바이오테크놀로지스 인코포레이티드 | Solid-state sequencing devices containing two-dimensional layer materials |
US10508296B2 (en) | 2017-04-25 | 2019-12-17 | Roswell Biotechnologies, Inc. | Enzymatic circuits for molecular sensors |
WO2018200687A1 (en) | 2017-04-25 | 2018-11-01 | Roswell Biotechnologies, Inc. | Enzymatic circuits for molecular sensors |
EP3622086A4 (en) | 2017-05-09 | 2021-04-21 | Roswell Biotechnologies, Inc | Binding probe circuits for molecular sensors |
WO2019046589A1 (en) | 2017-08-30 | 2019-03-07 | Roswell Biotechnologies, Inc. | Processive enzyme molecular electronic sensors for dna data storage |
WO2019075100A1 (en) | 2017-10-10 | 2019-04-18 | Roswell Biotechnologies, Inc. | Methods, apparatus and systems for amplification-free dna data storage |
US20200393440A1 (en) | 2019-04-05 | 2020-12-17 | Roswell Biotechnologies, Inc. | Method, apparatus and system for single-molecule polymerase biosensor with transition metal nanobridge |
-
2018
- 2018-04-25 WO PCT/US2018/029382 patent/WO2018200687A1/en unknown
- 2018-04-25 CA CA3057151A patent/CA3057151A1/en active Pending
- 2018-04-25 KR KR1020197033040A patent/KR102692957B1/en active IP Right Grant
- 2018-04-25 KR KR1020247026190A patent/KR20240122598A/en active Search and Examination
- 2018-04-25 EP EP18790713.4A patent/EP3615685A4/en active Pending
- 2018-04-25 CN CN201880026531.4A patent/CN110546276A/en active Pending
-
2019
- 2019-11-14 US US16/684,338 patent/US11268123B2/en active Active
-
2020
- 2020-12-30 US US17/138,314 patent/US20220002777A1/en active Pending
-
2022
- 2022-01-27 US US17/586,772 patent/US20220154241A1/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11621345B2 (en) * | 2018-08-14 | 2023-04-04 | Pawan Tyagi | Systems and methods of fabricating gate electrode on trenched bottom electrode based molecular spintronics device |
Also Published As
Publication number | Publication date |
---|---|
KR20240122598A (en) | 2024-08-12 |
WO2018200687A1 (en) | 2018-11-01 |
US20200157595A1 (en) | 2020-05-21 |
US11268123B2 (en) | 2022-03-08 |
KR20200002897A (en) | 2020-01-08 |
EP3615685A1 (en) | 2020-03-04 |
CA3057151A1 (en) | 2018-11-01 |
US20220002777A1 (en) | 2022-01-06 |
CN110546276A (en) | 2019-12-06 |
EP3615685A4 (en) | 2021-01-20 |
KR102692957B1 (en) | 2024-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10913966B2 (en) | Enzymatic circuits for molecular sensors | |
US11268123B2 (en) | Enzymatic circuits for molecular sensors | |
US11143617B2 (en) | Binding probe circuits for molecular sensors | |
Liu et al. | Single‐molecule detection of proteins using aptamer‐functionalized molecular electronic devices | |
JP5743974B2 (en) | Nanotube sensor device for DNA detection | |
CN112384296B (en) | Devices, systems and methods for direct electrical measurement of enzymatic activity | |
US20220098635A1 (en) | Bioelectronic circuits, systems and methods for preparing and using them | |
JP2022517952A (en) | Conductive synthetic peptides for molecular electronics | |
CN116018413A (en) | Bioelectronic device with programmable aptamer | |
WO2023086653A2 (en) | A molecular sensor and methods for use | |
WO2023167937A2 (en) | Peptide based bridges for molecular sensors and methods for use thereof | |
WO2024054632A2 (en) | N-terminal multifunctional conjugation of proteins and peptides for biosensing | |
WO2023089569A1 (en) | Directly functionalized electrochmical transisteors, and convection driven ultra-rapid detection of biomarkers using transistors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: WESTERN ALLIANCE BANK, AN ARIZONA CORPORATION, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:ROSWELL BIOTECHNOLOGIES, INC.;REEL/FRAME:061150/0104 Effective date: 20211101 |
|
AS | Assignment |
Owner name: PROCOPIO, CORY, HARGREAVES & SAVITCH LLP, CALIFORNIA Free format text: SECURITY INTEREST;ASSIGNOR:ROSWELL BIOTECHNOLOGIES, INC.;REEL/FRAME:063601/0105 Effective date: 20221208 |
|
AS | Assignment |
Owner name: ROSWELL ME INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ROSWELL BIOTECHNOLOGIES, INC.;REEL/FRAME:064073/0448 Effective date: 20230622 |
|
AS | Assignment |
Owner name: ROSWELL ME INC., CALIFORNIA Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:PROCOPIO, CORY, HARGREAVES & SAVITCH LLP;REEL/FRAME:065474/0214 Effective date: 20221230 |